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Abstract 
Damage to the spinal cord can disrupt the pathway of signals sent between the brain and 
the body and may result in partial or complete loss of both motor and sensory functions. The loss 
of these functions can have devastating implications on the quality of one’s life, interfering with 
activities of daily living related to walking, bladder and bowel control, trunk stability, and arm and 
hand function. Current approaches used to help improve and restore mobility require residual 
movement to control, which can be unintuitive and inoperative by individuals with higher level 
cervical injuries. In order to develop technology used by individuals of all levels of injury, it is 
necessary to generate control signals directly from the brain. This thesis is intended to address the 
clinical limitations of implantable neural recording systems, and thus lay the foundation for the 
development of a design and safety profile for a fully implantable intracortical system for motor 
restoration. 
We first present the design and testing of a 96-channel neural recording device used to 
mate with an existing functional electrical stimulation (FES) system in order to facilitate brain-
controlled FES. By extracting signal power within a narrow frequency bandwidth and reducing 
overhead processor operations, a 25% power reduction is achieved. This establishes the feasibility 
for an implantable system and enables the integration of the neural recording device with 
implantable FES system. The specifications of this platform can be used as a guide to develop 
further application specific modules and dramatically accelerate the overall process to a clinically 
viable system. 
xi 
 
With a functional device, the next step is to move towards a clinical trial. Here we 
investigate the potential safety risks of future modular, implantable neuroprosthetic systems. A 
systematic review of 240 articles was used to identify and quantitatively summarize the hardware-
related complications of the most established intracranial clinical system, deep brain stimulation, 
and the most widespread experimental human intracranial system, the NeuroPort, including the 
Utah microelectrode array. The safety and longevity data collected here will be used to better 
inform future device and clinical trial design and satisfy regulatory requirements. 
The stability and longevity of the Utah array are critical factors for determining whether 
the clinical benefit outweighs the risk for potential users. We investigate the biological adverse 
response to the insertion of the Utah array in a rhesus macaque. We examined the density of 
neurons around the shanks of the array in comparison to control brain. Non-human primate animal 
models allow us to further examine the effects of the implantation of the Utah array on neural 
tissue, which cannot be done with humans. Information gained through this will continue to 
increase the pool of safety data for the Utah array and emerging intracranial devices.  
Overall, we developed a neural recording device to be used for brain-controlled FES and 
examined the potential safety concerns reported in the human literature and experimentally using 
non-human primates. These results represent significant progress towards a clinically-viable 
system for motor restoration in people suffering from spinal cord injury.  
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Chapter 1 
Introduction 
 
The prevalence of paralysis is represented by a large segment of the US population, 
affecting nearly 1 in 50 Americans (Armour, Courtney-Long, Fox, Fredine, & Cahill, 2016). Spinal 
cord injury (SCI), the second leading cause of paralysis is estimated to affect approximately 
288,000 persons with 17,700 new cases each year (National Spinal Cord Injury Statistical Center, 
2016). Damage to the spinal cord disrupts the signal pathway used in communication between the 
central and the peripheral nervous systems and can result in the loss of motor and sensory functions 
below the level of injury. The location of the damage to the spinal cord will determine the severity 
of the paralysis experienced. This loss of motor function creates functional limitations that have 
the ability to drastically impact the quality of one’s life. Currently there are no adequate clinical 
solutions available to people living with paralysis. Most individuals require around the clock 
assistance to fulfill daily functional tasks, which can be cost intensive and deprive one of their 
sense of independence. Based on surveys of the quadriplegic population, it was emphasized that 
the restoration of arm and hand function would be most important to improve their quality of life 
(Anderson, 2004). This would help restore some level of self-sufficiency and allow them to interact 
with their surroundings.  
Current clinical approaches to restore hand function, outside of relying on a full-time 
caretaker, have been limited to both muscle-controlled prosthesis and functional electrical 
stimulation (FES) systems. This technology has been useful in assisting those with partial 
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paralysis. However, these methods of control can be counterintuitive to the normal process of 
movement. In addition, these methods require a level of residual movement of the shoulder or 
limbs to use these assistive devices, therefore excluding a subset of the SCI population. In order 
to address this fundamental limitation, it becomes necessary to extract motor intent directly from 
the brain. By interfacing cortical signals, we can provide a more natural control solution and 
expand function to individuals with all levels of injury.   
The following sections will discuss current experimental approaches to restoring hand 
function after spinal cord injury, the limitations towards clinical adoption, and present 
opportunities for improvements to accelerate the process towards a clinically-viable system. 
 
1.1 Recent Advances in Motor Restoration through Human Brain Machine Interfaces  
1.1.1 Human Intracortical Neural Interface Technology 
Extracting signals directly from the brain for motor control has been done using a variety 
of neural interface technologies. These neural interfaces range in their level of invasiveness and 
signal specificity. Noninvasive technologies such as electroencephalography (EEG) and 
electrocorticography (ECoG) have demonstrated the potential to control computer cursors and 
robotic arms (Farwell & Donchin, 1988; Hotson et al., 2016; Leuthardt, Schalk, Wolpaw, 
Ojemann, & Moran, 2004; Pistohl, Ball, Schulze-Bonhage, Aertsen, & Mehring, 2008; Schalk et 
al., 2007; Wolpaw, McFarland, Neat, & Forneris, 1991).  However, while these interfaces could 
be readily adopted due to their less invasive implementation, they do not provide control signals 
with the high specificity needed to execute more advanced tasks. Early experiments have shown 
that a more invasive method, extracting signals using electrodes implanted in motor cortex, might 
provide a better source for control signals. (D. R. Humphrey, Schmidt, & Thompson, 1970; D. S. 
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Humphrey & Hochberg, 1995). Intracortical electrodes that penetrate the brain are in close 
proximity, which enables them to record activity from individual neurons or a small population of 
neurons, thus extracting the most information.  
The first effort to translate invasive single neuron recordings to humans used a neurotrophic 
electrode, consisting of a hollow glass conical tip with two gold recording wires. This technology 
was used in patients with ALS and brainstem stroke to control computer cursors (Kennedy & 
Bakay, 1998; Kennedy, Bakay, Moore, Adams, & Goldwaithe, 2000). In order to control multiple 
degrees of freedom and increase the difficulty of tasks, more recording electrodes are needed. The 
development of the Utah intracortical electrode array permitted the implantation and simultaneous 
recording of a larger number of electrodes (Nordhausen, Maynard, & Normann, 1996; 
Nordhausen, Rousche, & Normann, 1994). The Utah array is a 4 mm x 4 mm silicon-based 
microelectrode array with 100 recording electrode shanks that extend 1.5 mm. Once 
commercialized, this recording structure became a breakthrough in translating brain machine 
interfaces from animal studies to clinical research in humans. This is currently the only invasive 
neural interface that has FDA approval for human testing (Cyberkinetics, 2005). Utah arrays have 
been used in people to control computer cursors and robotic arms (Hochberg et al., 2006; S.-P. 
Kim, Simeral, Hochberg, Donoghue, & Black, 2008), as well as study epilepsy (Weiss et al., 2013), 
memory (Rutishauser, Aflalo, Rosario, Pouratian, & Andersen, 2018), consciousness (Hanrahan 
et al., 2013), and sensory responses (Armenta Salas et al., 2018a). 
1.1.2 Neural Prosthesis 
Extraction of motor intent directly from the brain, using brain machine interfaces (BMIs) 
has shown to be very promising in generating control signals for prosthetic devices (Collinger et 
al., 2013a; Hochberg et al., 2012b; Z. T. Irwin…Bullard et al., 2017; Pandarinath et al., 2018). 
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This concept was first demonstrated during the BrainGate clinical trial, with the first implantation 
of the Utah array in a human. Intracortical signals were used to control a two-dimensional cursor 
and rudimentary movements of a robotic arm by individuals with tetraplegia (Hochberg et al., 
2006; S.-P. Kim et al., 2008). With ongoing research and improved interpretation of neural 
ensembles using machine learning algorithms, three-dimensional control of prosthetics has been 
used by people with tetraplegia to perform reaching and grasping with increased degrees of 
freedom for functional tasks (Collinger et al., 2013a; Hochberg et al., 2012b; Wodlinger et al., 
2015a). These studies have focused on decoding movement to control external prosthetic arms and 
restore motor function to tetraplegics. However, with SCI the anatomy to execute movement 
remains intact and grants the option to reanimate the paralyzed limb. This alternative restores the 
natural extremity rather than using an external assistive device and is more desirable to people 
living with SCI (Blabe et al., 2015). 
1.1.3 Functional Electrical Stimulation 
Functional electrical stimulation allows the signal pathway within the spinal cord that 
initiates movement to be bypassed. Electrical stimulation is applied directly to the nerve 
innervating muscle to produce movement. FES has made great strides in restoring a variety of 
motor functions, assisting patients with grasping objects (Peckham et al., 1998, Kilgore et al., 
2008, Popovic et al., 2002, Alon et al., 2003), walking (Thrasher et al., 2006, Daly et al., 2008), 
and controlling bladder functions (Gaunt et al., 2006). 
 Most commercially-available FES systems for hand function have been controlled by the 
user via physical switches, shoulder motion, and wrist position which allow patients to cycle 
through pre-programmed stimulation patterns (Snoek et al., 2000, Prochazka et al., 19997, Handa 
et al., 1992, Smith et al., 1987). These previous methods provided somewhat coarse and binary 
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control of the limb. Current FES systems use residual myoelectric activity or joint angles as a 
method of control to achieve more finely tuned movements (Memberg et al., 2014, Smith et al., 
1998). The Freehand system was one of the first implanted FES systems, and was part of the largest 
clinical trial of an upper extremity neuroprosthesis (Taylor, Esnouf, & Hobby, 2002). It has since 
been removed from the market. However, Case Western Reserve University recently developed 
the Networked Neuroprosthesis (NNP), a next-generation system of implantable modules for FES.  
This fully implantable system can record residual EMG and perform many combinations of neural 
stimulation for controlling grasp and other motor functions (Smith, Crish, Buckett, Kilgore, & 
Peckham, 2005). Although these current methods perform well for individuals with partial 
paralysis, as the level of SCI increases and residual motor function decreases, there are fewer 
options for control sources of such systems.   
More recently, groups have successfully recorded signals directly from motor cortex using 
Utah arrays to predict movements or EMG patterns and control FES systems (Ethier et al., 2012, 
Ajiboye et al., 2012, Bouton et al., 2016). Bouton et al. demonstrated that multiunit activity in a 
paralyzed human could be used to control muscle activation through surface stimulation and 
provide continuous control of isolated finger movements and six different wrist and hand postures 
(Bouton et al., 2016). Ajiboye et al. enabled a person with a C3 level injury to perform self-feeding 
activities using intracortically-controlled stimulation through percutaneous electrodes (Ajiboye et 
al., 2017).  
 
1.2 Clinical Limitations of Implantable Neural Recording Systems  
 Although promising, all previous demonstrations of cortically-controlled systems to restore 
arm and hand function have required the connection of indwelling electrodes to external hardware 
outside of the body. This increases the potential risk of infection and impedes the portability of the 
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system, confining the user to a purely research setting. To avoid any transcutaneous leads and 
move towards a practical device for clinical use, active electronics for processing the neural signals 
must be fully implantable.  
1.2.1 Design 
 Many groups have designed and built custom implantable, wireless neural recording 
devices (Aziz et al., 2009; Borton, Yin, Aceros, & Nurmikko, 2013; Gao et al., 2012; Miranda, 
Gilja, Chestek, Shenoy, & Meng, 2012; Moo Sung Chae, Zhi Yang, Yuce, Linh Hoang, & Liu, 
2009; S.-Y. Park, Cho, Na, & Yoon, 2018; Rizk et al., 2009; Wattanapanitch & Sarpeshkar, 2011) 
. However, none have been FDA approved or tested in humans. Almost all of these circuits were 
developed around specifications from basic neuroscience, in which the action potential waveform 
must be captured. In order to accomplish this, typical neural recording systems must sample the 
signal at >20kHz and digitize at a 16-bit resolution.  
One of the major challenges in translating these systems into clinical use is the high 
bandwidth needed to access individual neural waveforms. The high sampling rate required to 
process and transmit neural data dramatically increases the power consumption of the device and 
can result in short battery life and increased device temperatures (Borton et al., 2013; Harrison et 
al., 2009; Miranda, Gilja, Chestek, Shenoy, & Meng, 2010). Borton et al. developed a 100 channel, 
hermetically sealed, implantable neural recording system. This device transmits broadband data at 
24Mbps, requires 90.6mW, and can last 7 hours on a medical grade 200mAh battery (Borton et 
al., 2013).  Similarly, Miranda et al. developed a 32-channel system of primarily off the shelf 
components that delivered broadband data at 24 Mbps, using 142mW (Miranda et al., 2010). This 
system can last up to 33 hours, but requires two 1200 mAh batteries. Rizk et al. built a 96-channel 
implantable system powered through inductively-coupled coils which requires 2000mW (Rizk et 
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al., 2009). When compared to a pacemaker, which can run on µW and last approximately six years, 
the previous systems draw too much power to run on an implantable battery and are beyond the 
specifications of existing implantable devices.  
1.2.2 Safety 
 An implantable neural recording device must also meet regulatory requirements before 
being introduced to the market. The FDA classifies medical devices on a scale of one to three 
based on the risk they impose. This class will determine the path taken to market and the 
requirements of safety and efficacy to be demonstrated. These requirements can have major 
implications on the time, money, and amount of participants needed. In order to test an implantable 
neural recording device in humans the FDA must grant an investigational device exemption (IDE). 
The IDE proposes that the risk to human subjects does not outweigh the benefits and the knowledge 
gained, and further allows the collection of safety and efficacy data on the device through a clinical 
trial. Inherently, the main priority of the FDA is safety. They look for adverse and serious adverse 
events within clinical trials to make judgements on the safety of the device. Therefore, to ensure 
human clinical trials are conducted efficiently and effectively it is critical to identify potential 
sources of complications and estimate safety risks in advance. Unfortunately, because there have 
not been any other implantable neural recording devices approved by the FDA, there is a lack of 
safety data available. However, safety analyses of existing technology can be used as a benchmark 
to infer important information about the safety of the device. 
As a major component of an implantable neural recording device, the Utah array can be 
examined. While human safety data is limited, animal models can be used to learn more. There 
are still many safety and efficacy challenges that pose a threat to the longevity, stability, and quality 
of the arrays for clinical use in BMI control; mechanical damage of the electrode, degradation of 
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electrode materials, and the response of the brain against the implanted device. Baresse et al., 2013 
investigated long-term modes of failure of 78 Utah arrays over 27 non-human primates. They 
demonstrated that most arrays failed within a year of implantation, most commonly of mechanical 
failures due to connector issues. Biological issues were the second most common, accounting for 
24% of failures. There were reported recordings for about 6 years, however a slow progressive 
decline in spike amplitude and the number of viable channels was noted (Baresse, et al., 2013). 
However, even with spike amplitude decrease throughout the first year, signals can still stabilize 
without loss of information content because the multiunit amplitude remains well above the noise 
(Chestek et al., 2011). In a follow up study, they used SEM techniques to visualize structural 
changes of explanted arrays from non-human primates to identify potential reasons for this signal 
attenuation. The SEM revealed material deficits of parylene cracking and platinum tip corrosion 
which progressed the longer they were implanted. A considerable amount of tissue encapsulation 
had grown into the platinum and parylene defects and was also suggested to have lifted the array 
out of the brain (Baresse et al., 2016). Consequently, the implantation of the array can also induce 
neural tissue and vascular damage having adverse effects on the health of the brain. During 
insertion of electrodes, neurons are killed, blood vessels are disrupted and the blood brain barrier 
(BBB) is compromised, which can result in micro hemorrhages and other cellular responses to the 
implanted device (Fernandez et al., 2014). Research on BBB disruption and techniques to reduce 
damage has been done as a result of this. Kozai et al., 2010 discovered that by inserting in areas 
over 5 µm away from any major sub-surface vessels could reduce neurovascular damage by about 
83%. 
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1.3 Summary of thesis 
In this thesis, we examine the feasibility of using the Utah microelectrode array for long-
term implantable, modular neural prosthesis systems in humans. We intend to address the clinical 
limitations of implantable neural recording systems, and thus lay the foundation for the 
development of a design and safety profile for a fully implantable intracortical system for motor 
restoration. 
In Chapter 2, we present the design and testing of a novel implantable neural recording 
device. This neural recording device was designed to access 96 channels from the Utah 
microelectrode array and process the data in low power. Power reduction is enabled by the 
extraction of signal power in a narrow frequency bandwidth along with the use of several features 
of the microcontroller that reduce overhead processor operations. The device architecture was 
designed to be used as a module in conjunction with an existing, fully implantable, functional 
electrical stimulation system to facilitate cortical-controlled FES. Specifications expressed in this 
chapter represent the first attempt to combine designs from different groups. This platform can be 
used as a guide to develop further application specific modules and dramatically accelerate the 
overall process to a clinically viable system.  
In Chapter 3, we examine the safety profiles of the most widespread, established 
intracranial clinical system, deep brain stimulation, and the most widespread experimental human 
intracranial system, the NeuroPort, including the Utah microelectrode array. We identify and 
quantitatively summarize the hardware-related complications of deep brain stimulation that can be 
used to estimate potential safety risks of future modular, implantable neuroprosthetic systems. In 
addition, we collect longevity data for human Utah array implants. Due to the lack of data reported 
in literature discussing human research using the Utah array, we determined in order to continue 
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to establish a database of safety data for future and emerging neuromodulation technologies we 
need to be gathering detailed information about the implantations during experiments such as 
implant and explant dates, detailed per patient adverse events, the time frame in which adverse 
events occurred, as well as the responsive action. This data will better inform future device and 
clinical trial design and satisfy regulatory requirements. 
 In Chapter 4, we study incidental safety data from a rhesus macaque implanted with the 
Utah array. Histology was performed on neural tissue of the area beneath and surrounding the 
explanted array. The tissue was stained for neurons, microglia, and nuclear cells. We examined 
the density of neurons around the shanks of the array in comparison to control brain from three 
different slices of varying depths along the electrode array. Non-human primate animal models 
allow us to further examine the effects of the implantation of the Utah array on neural tissue, which 
cannot be done with humans. Information gained through this will continue to increase the pool of 
safety data for the Utah array and emerging intracranial devices.  
Chapter 5 will summarize the results of each study and discuss future directions to advance 
the development and distribution of implantable neuroprostheses. 
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Chapter 2 
Design and Testing of a 96-Channel Neural Interface Module for the Networked 
Neuroprosthesis System 
 
A version of this chapter has been published to Bioelectronic Medicine. 
Bullard, A. J., Nason, S. R., Irwin, Z. T., Nu, C. S., Smith, B., Campean, A., Peckham, P. H., 
Kilgore, K. L., Willsey, M. S., Patil, P. G., Chestek, C. A. (2019). Design and testing of a 96-
channel neural interface module for the Networked Neuroprosthesis system. Bioelectronic 
Medicine, 5(1), 3. 
 
 2.1 Abstract 
The loss of motor functions resulting from spinal cord injury can have devastating 
implications on the quality of one’s life. Functional electrical stimulation has been used to help 
restore mobility, however, current functional electrical stimulation (FES) systems require residual 
movements to control stimulation patterns, which may be unintuitive and not useful for individuals 
with higher level cervical injuries. Brain machine interfaces (BMI) offer a promising approach for 
controlling such systems; however, they currently still require transcutaneous leads connecting 
indwelling electrodes to external recording devices. While several wireless BMI systems have 
been designed, high signal bandwidth requirements limit clinical translation. Case Western 
Reserve University has developed an implantable, modular FES system, the Networked 
Neuroprosthesis (NNP), to perform combinations of myoelectric recording and neural stimulation 
for controlling motor functions. However, currently the existing module capabilities are not 
sufficient for intracortical recordings. Here we designed and tested a 1x4 cm, 96-channel neural 
recording module prototype to fit within the specifications to mate with the NNP. The neural 
recording module extracts power between 0.3-1 kHz, instead of transmitting the raw, high 
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bandwidth neural data to decrease power requirements. The module consumed 33.6 mW while 
sampling 96 channels at approximately 2 kSps. We also investigated the relationship between 
average spiking band power and neural spike rate, which produced a maximum correlation of 
R=0.8656 (Monkey N) and R=0.8027 (Monkey W). Our experimental results show that we can 
record and transmit 96 channels at 2ksps within the power restrictions of the NNP system and 
successfully communicate over the NNP network. We believe this device can be used as an 
extension to the NNP to produce a clinically viable, fully implantable, intracortically-controlled 
FES system and advance the field of bioelectronic medicine. 
 
2.2 Introduction 
According to the National Spinal Cord Injury Statistical Center, there are approximately 
282,000 people living with chronic spinal cord injury (SCI), with 17,000 new cases occurring each 
year (National Spinal Cord Injury Statistical Center, 2016). Damage to the spinal cord can disrupt 
the pathway of signals sent between the brain and the body and may result in partial or complete 
loss of both motor and sensory functions below the level of injury. The loss of these functions can 
have a major impact and severely interfere with activities of daily living related to arm and hand 
function, walking, bladder and bowel control, and trunk stability. Interestingly, restoration of arm 
and hand function was ranked as the highest priority amongst individuals with tetraplegia and 
could significantly improve quality of life (Anderson, 2004). Functional electrical stimulation 
(FES), a technique that uses pulses of electrical current to generate contractions of muscles, has 
been beneficial in assisting and improving the impaired motor function in individuals with SCI. 
FES has made great strides in improving not only hand function (Peckham, Mortimer, and 
Marsolais 1980; Alon and McBride 2003; Popovic, Popovic, and Keller 2002; Kilgore et al. 2008), 
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but also walking (Daly et al., 2011; Thrasher, Flett, & Popovic, 2006), and controlling bladder 
functions (Gaunt & Prochazka, 2006). 
FES systems have been controlled by the user via physical switches, shoulder motion, and 
wrist position, which allow patients to cycle through pre-programmed stimulation patterns 
(Prochazka et al. 1997; Snoek et al. 2000; Handa et al. 1992; Johnson et al. 1999; Smith et al. 
1987). These previous methods provided somewhat coarse and binary control of the limb. Current 
FES systems use residual myoelectric activity or joint angles as a method of control to achieve 
more finely tuned movements (Memberg et al., 2014; Smith et al., 1987). Although these current 
methods may work for individuals with partial paralysis, they can be unintuitive for patients and 
only provide a few degrees of freedom. Further, in high cervical SCI, there is little or no residual 
motor function to provide an appropriate input stimulus to control such systems. Thus, a control 
solution which can provide more function to patients with all levels of injury is needed. 
Brain machine interfaces (BMIs) have demonstrated great potential for generating control 
signals for prosthetic devices (Chapin, Moxon, Markowitz, & Nicolelis, 1999; Collinger et al., 
2013a; Gilja et al., 2015b; Hochberg et al., 2012a; Velliste, Perel, Spalding, Whitford, & Schwartz, 
2008). The capability of BMIs to decode intended movement directly from the brain can also be 
used to control FES systems, potentially restoring natural function to patients with all levels of 
spinal cord injury. Recently, groups have successfully used intracortically recorded signals from 
Utah microelectrode arrays (Blackrock Microsystems, Salt Lake City, UT) to predict movements 
or electromyogram (EMG) patterns to control FES systems (Ajiboye, Simeral, Donoghue, 
Hochberg, & Kirsch, 2012a; Bouton et al., 2016; Ethier, Oby, Bauman, & Miller, 2012). Bouton 
et al. demonstrated that multiunit activity in a paralyzed human could be used to control muscle 
activation directly and provide continuous control of isolated finger movements and six different 
5 
 
wrist and hand postures (Bouton et al., 2016). Most recently, Ajiboye et al. enabled a person with 
a C3 level injury to perform self-feeding activities using Utah array-controlled FES (Ajiboye et 
al., 2017). Although cortical control of FES is promising, current BMIs still require percutaneous 
leads connecting indwelling electrodes to external recording devices that can lead to risk infection 
and limits portability. Therefore, wireless technology is required to move towards a fully 
implantable and clinically viable device. 
Many groups have designed and built custom implantable, wireless neural recording 
devices (Aziz et al., n.d.; Gao et al., 2012; Moo Sung Chae et al., 2009; S.-Y. Park et al., 2018; 
Wattanapanitch & Sarpeshkar, 2011) . However, none have been FDA approved or tested in 
humans. One of the major challenges in translating these systems into clinical use is the high 
bandwidth needed to access individual neural waveforms. The need to acquire, process, and 
transmit this broadband neural data dramatically increases the power requirements of the device, 
which results in large batteries with low battery life. For example, Borton et al. developed a 100 
channel, hermetically sealed, implantable neural recording system. This device transmits 
broadband data at 24Mbps, requires 90.6mW, and can last 7 hours on a medical grade 200mAh 
battery (Borton et al., 2013). Similarly, Miranda et al. developed a 32-channel system of primarily 
off the shelf components that delivered broadband data at 24 Mbps, using 142mW (Miranda et al., 
2010). This system can last up to 33 hours but requires two 1200 mAh batteries. In all cases, the 
high power requirement prevents the use of compact batteries with adequate battery life practical 
for an implantable device.  
One method for saving power is to reduce the system bandwidth by focusing on relevant 
BMI features of the intracortical signals. Intracortical BMIs typically analyze the action potential 
or “spikes” frequencies. Spikes are detected in the broadband signal by setting thresholds and 
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counting the number of crossings in regular time intervals. These spike counts can be used to 
predict both continuous and discrete movements. Spike sorting individual neurons may be 
beneficial if an electrode is recording neurons with independent tuning patterns, otherwise, if 
electrodes primarily have only one neuron or similarly tuned neurons then a substantial 
performance gain is not expected. Numerous studies have used thresholded spikes in BMI 
experiments and have shown that there is minimal or no performance loss when compared to sorted 
action potentials extracted from the broadband data (Chestek et al., 2011; Fraser, Chase, Whitford, 
& Schwartz, 2009). In investigation of spike sorted data in comparison to thresholded data for the 
use in BMIs we have previously shown that spike sorting does not substantially improve decoding 
performance. Using a Naïve Bayes classifier with both thresholded and spike sorted data, we 
demonstrated percent accuracy only changed by an average of 5% and the correlation coefficient 
only differed by 0.015 (Christie et al., 2015). Thus, instead of transmitting the entire broadband 
signal, only the spike counts are needed to generate commands (Harrison et al., 2009). This 
immensely compresses the data, decreasing the required data rate for transmission. Beyond using 
spike counts, Stark and Abeles found that most of the decoding information received from spikes 
could also be found in the signal frequency band of 300-6,000 Hz, which includes the spike 
waveform frequencies (Stark & Abeles, 2007).  We have previously shown this bandwidth can be 
further reduced to 300-1,000 Hz and extract similar intracortical information (Irwin…Bullard et 
al., 2016). We refer to this 300-1,000 Hz band as the “spiking band”. Specifically, we developed 
a 16-channel wireless neural interface to assess the power savings and BMI decoder performance 
of this approach. We compared the decode performance of continuous finger position using a 
Wiener filter between high bandwidth data using spike counts and low bandwidth data using the 
spiking band. That study showed that instead of transmitting the entire broadband signal, extracting 
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only signal power within a narrow frequency band allowed for a reduced sampling rate and resulted 
in a power savings of roughly 90% with only a 5% performance loss of the accuracy of the decoder 
(Irwin…Bullard et al., 2016). This approach could be applied in the context of existing fully 
implantable systems to decrease power consumption and allow for practical neural control of FES 
devices. 
One efficient way to move the field towards a fully implantable intracortical BMI-FES 
system for clinical use may be to merge a neural recording device with an already existing fully 
implantable FES system. Using similar signal processing techniques from our previous wireless 
device (Irwin…Bullard et al., 2016), we developed a novel 96-channel intracortical recording 
device to be used as an extension to the modular, fully implantable FES system developed at Case 
Western Reserve University. In this paper we describe a feasibility study for power, performance, 
and form factor to mate with their system and the prospect of an implantable cortical-controlled 
FES system.  
 
2.3   Methods 
2.3.1 Networked Neuroprosthesis System 
The Networked Neuroprosthesis (NNP) is a system of implantable modules used to record 
residual EMG and perform many combinations of neural stimulation for controlling grasp and 
other motor functions (Smith et al., 2005). While other implantable FES systems and modular 
networks have been developed (Ghoreishizadeh, Haci, Liu, Donaldson, & Constandinou, 2017; 
Guiraud, Azevedo Coste, Benoussaad, & Fattal, 2014; Jovičić, Saranovac, & Popović, 2012), to 
our knowledge, the NNP is currently the only fully implantable FES system in initial human testing 
for hand function. It consists of a single central power module, and multiple actuator and sensor 
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modules that are all interconnected via a network cable. The central power module is used for 
battery housing and wireless transfer. It manages power distribution and has the capability to 
monitor and program functions to other modules throughout the network. The actuator module is 
responsible for providing stimulation to muscles or nerves while the sensor module records 
biopotential data. The network cable provides the power and high-speed data link for the modules 
with a two wire Controller Area Network-like (CAN) bus protocol (US 7,260,436 B2, 2007; Smith 
et al., 2005).  
The current NNP sensor modules are designed with two bipolar channels to record EMG. 
These sensor modules are not equipped to support 96-channel intracortical neural recordings. 
However, the NNP system architecture was designed as a platform technology to accept new 
modules with added functionality. Theoretically, a separate 96-channel neural recording module 
can be added to the NNP system to facilitate cortical controlled FES. This module would need to 
adhere to the guidelines of the standard NNP sensor modules: fit into the approved 1 cm x 3 cm 
hermetically sealed packaging of the sensor modules, include CAN capabilities, and meet the 
requirements of the 50kbps network bandwidth and the target power consumption of about 30 
mW. Because the NNP has been cleared for human testing and offers an open architecture, we 
chose this as our base system to test the feasibility of a fully implantable, cortically controlled 
FES system. The final system will record neural data from a 96-channel Utah array and generate 
command signals for grasping using low power circuitry and the spiking band feature extraction 
technique. Herein, we present the design and experimental results of this neural recording 
module prototype, including validation using novel datasets with intracortical recordings from 
rhesus macaques performing finger movements. 
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2.3.2 Cortical Controlled FES System Overview 
The envisioned intracortical FES system is shown in figure 2.1. The existing NNP 
architecture is used for muscle stimulation, power, and communication, while the novel 
intracortical recording module presented here generates control signals based on user intention. 
The novel recording module records data from a 96-channel Utah array in motor cortex, extracts 
the signal power in the 300-1,000 Hz frequency band, and will ultimately predict the user’s motor 
intention using decoding techniques similarly to (Irwin…Bullard et al., 2016). That intention is 
then converted into appropriate stimulation patterns by the power module and stimulates the 
paralyzed limb via the actuator module. The central power module of the NNP provides power to 
all sensor and actuator modules and provides a communication pathway both between modules 
and for external programming.  
The Utah array will be directly wire bonded to the neural recording module in a 
hermetically sealed capsule which will be secured to the skull, similar to what is seen with the 
Responsive Neurostimulator system (Neuropace). Securing this module to the skull should limit 
cable length and the possibility of excessive noise or interferance of the signal. The neural 
recording module will then be connected to other modules of the NNP throughout the body via the 
network cable. 
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Figure 2.1. Concept diagram for brain-controlled FES. The grey box denotes the existing NNP system 
and the red box denotes the planned novel module. 
 
2.3.3 Recording Module Hardware Design 
The initial design specifications for this module, summarized in table 2.1, were determined 
based on the existing design of the Networked Neuroprosthesis system from Case Western and 
from the design of our previous wireless system (Irwin…Bullard et al., 2016). The recording 
module is described by the block diagram in figure 2.2. It has a 96-channel front-end which filters 
and digitizes the incoming neural data. The absolute value of the data on each channel is binned 
by the central microcontroller of the device by averaging over a given time interval to calculate 
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the mean signal power. Decoding and communication over the CAN bus have not yet been 
implemented. However, in the future, the power on all channels will be decoded by the central 
microcontroller to predict the user’s intended grasp type. Finally, the decoded grasp type will be 
sent over the network to the NNP modules for appropriate muscle stimulation. Here, we validate 
the module’s ability to record the neural data at power levels that will work in conjunction with 
the entire system.  
 
Figure 2.2. Block diagram of the neural recording module. (*) indicates future work not presented here. 
 
The module was implemented using entirely commercial, off-the-shelf components. The 
front-end consists of three Intan RHD2132 32-channel bioamplifiers that combine analog and 
digital filters and a multiplexed 16-bit ADC. The upper and lower bandwidths of the amplifiers 
and number of active channels can be easily configured by the central microcontroller (MCU) via 
a standard four-wire SPI interface. The MCU has three USART ports that are configured for SPI 
to transmit data from all three amplifiers simultaneously. The lower cutoff frequency of the 
amplifier bank is adjustable from 0.1–500 Hz, while the upper cutoff range is 100–20,000 Hz. The 
ADC sampling rate is controlled by the MCU, which was set to approximately 2 kSps per channel 
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when using all 96 channels to measure signal power, or approximately 30 kSps for a single 
channel’s single unit recording. The power consumption of the amplifiers is proportional to the 
upper cut off frequency and scales at 7.6 µA/kHz per channel. The chosen upper cut off frequency 
is the major factor in power consumption of the amplifiers. The upper cut off frequency also 
determines the minimum sampling rate that can be applied, which is a major factor on the MCU 
and power consumption of the overall system. 
 A 32-bit Atmel ATUC3C2256C MCU serves as the central controller and data processor, 
configuring the front-end amplifiers, controlling the rate of data flow, as well as eventually 
communicating with existing NNP circuitry via a CAN-like bus.  Feature extraction from the data 
is performed on the MCU by averaging the absolute value of the data over a specified bin size that 
is programmed, which we define as spiking band power. The MCU is clocked via an external 
crystal oscillator at 8 MHz which is internally divided for device operation and SPI 
communication. The MCU is programmed from an external computer via a ten-pin AVR JTAG 
interface, and system configuration settings can be easily modified in the application code. 
 The MCU’s Direct Memory Access (DMA) controller allows sampling of the bioamplifiers 
without processor oversight and was used to save power.  The system is configured to initialize 
the 8 MHz clock, USART modules, and Intan amplifiers using the fully active MCU at startup. 
After initialization, the DMA controller is then set up to sample data using the USART peripheral 
(in SPI mode) and transfer it to internal memory. Once it is enabled, the MCU enters a low-power 
sleep mode. Since the USART module has a lower bit resolution than the Intan amplifiers, a small 
amount of glue logic was required to drive the MCU’s SPI interface to each amplifier while the 
MCU remained asleep. A D-flip flop, AND-gate, and necessary propagation delay circuitry were 
added to each chip select line on each SPI bus to drive the MCU’s SPI interface for compatibility  
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 with each amplifier while the MCU remained asleep. 
 The remaining circuitry is responsible for network communication and power 
conditioning. This section uses identical components and a similar layout as the existing modules 
of the NNP.  The network is designed to be DC isolated and is used to communicate with other 
NNP modules using the CAN bus protocol. The power conditioning circuitry will ultimately be 
responsible for harvesting power from the network. 
2.3.4 Printed Circuit Board Layout 
NNP remote modules are designed to have several 1cm wide rigid printed circuit board 
(PCB) panels, connected via flexible PCBs. This enables the modules to be folded to fit in a 1cm 
wide enclosure, while maintaining component layout space. These modules can additionally 
accommodate variable length enclosures, and designers have the choice of trading off module 
length for circuit board density and complexity. 
The novel module described thus far was prototyped on a six-layer printed circuit board. 
The prototype layout is shown in figure 2.3. All active circuitry fit within three 1cm x 4 cm panels 
in order to test the feasibility of fitting within an NNP package. Ultimately, a fourth panel will be 
Parameter Value 
Area 
# channels 
ADC resolution 
Amplifier input noise 
CPU clock 
Low-pass filter 
High-pass filter 
Sampling rate 
 
Supply voltage 
 
1.0 x 4.0 cm 
96* 
16 bits 
2.4 µVRMS 
8 MHz 
0.1 – 20 kHz* 
0.1 – 500 Hz* 
2.17 kSps (96 channels) 
32.05 kSps (1 channel) 
3.3 V 
  
*Configurable in software 
Table 2.1. Neural Recording Module Specifications 
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used comprised of all bond pads to connect internal circuitry to the external electrode array.  The 
limiting factor was the 32-channel Intan chips. All three Intan bioamplifiers were put on one panel 
with signal lines extending out from the side of the board. This solution required an extension of 
the board length from 3 cm for a typical NNP module to 4 cm for the novel module. A total of 12 
signal lines pass between the bioamplifier and microcontroller panels, four SPI lines for each 
amplifier, all on one inner layer. In addition, only four lines pass between the microcontroller panel 
and the communication and power panel. This will enable future versions to be fabricated with a 
rigid-flex circuit board that allows folding to fit within an NNP remote module enclosure 
(illustrated in figure 2.4). Most of the components outside of these panels are only used to facilitate 
benchtop testing and are not required for device operation. This includes test points, programming 
headers, and Samtec connectors that can connect directly to a Utah array head stage (Blackrock 
Microsystems). The remaining glue logic components were later added unconstrained to the 
outlined panels to avoid any major design changes; however, they could fit with the necessary 
adjustments. 
2.3.5 Experimental Design and Device Validation 
We explored the module’s ability to record in single channel (30 kSps) and multichannel 
(2 kSps) modalities. The sampling rate is approximate and can vary slightly based on code 
configurations. In each modality, the power consumption and its correlation to channel count was 
analyzed. In addition, we used the module to investigate the relationship between spiking band 
power and the firing rate of action potentials. This neural recording module was validated using 
pre-recorded data that was played back through the module and in vivo intracortical recordings 
directly from a rhesus macaque. All animal procedures were approved by the University of 
Michigan Institutional Review Board and the Institutional Animal Care & Use Committee. 
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Figure 2.3. Prototype board used for testing. Three panels (left to right): bioamplifiers, microcontroller, 
network and power circuitry. 
 
Figure 2.4. Example mockup of the final design with flexible circuitry. Demonstration of folded board to 
fit within the NNP module can. 
 
2.3.6 Surgical Implantation & Electrophysiology 
Two rhesus macaque monkeys were induced under general anesthesia and placed in a 
stereotactic frame. The craniotomy site was located using the stereotactic frame to estimate the 
location of the central sulcus. The hand region of primary motor cortex (M1) was approximated 
16 
 
by projecting a line from the genu of the arcuate sulcus posteriorly toward the gyrus immediately 
anterior to the central sulcus. The location of hand in the somatosensory cortex (S1) was 
approximated as the gyrus immediately posterior to the central sulcus across from the motor hand 
region. Two 4 mm x 4mm, 96-channel, intracortical Utah arrays (Blackrock Microsystems) were 
implanted in motor and sensory hand region as shown in figure 2.5. 
Broadband data were recorded at 30 kSps from the arrays using a Cerebus Neural Signal 
Processor (Blackrock Microsystems). Neural spikes were detected by high-pass filtering the raw 
data at 250 Hz and thresholding the resulting signal at -4.5 times the RMS voltage on each channel, 
similar to other experiments (Gilja et al., 2015b). 
 
Figure 2.5. (Top) Surgical photo of Utah arrays implanted in the motor and sensory cortex of a rhesus 
macaque. A – anterior, L – lateral, CS – central sulcus. (Bottom) Spike panel recorded from the M1 array 
using a Cerebus Neural Signal Processor (Blackrock Microsystems) illustrating the number of single units 
and their quality. Data from this monkey was used in later analysis to validate the device offline and in 
vivo. 
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2.3.7 Experimental Setup 
Data Playback 
Validation of the module in both single channel and multichannel modes were performed 
using pre-recorded data. Broadband data that had been previously recorded through the Cerebus 
(Blackrock Microsystems) and saved to an external computer were replayed through the module 
using a National Instruments DAQ card (PCI-6711) and then sent to a computer to view for further 
analyses, shown in figure 2.6 (A). The DAQ was a 12-bit, 4 channel, 1 MS/s analog output device. 
This was used in conjunction with a shielded connector box (NI SCB-68A) to access the channels 
and connected to the module via Samtec connectors. The output of the DAQ was adjusted via a 
voltage divider in order to achieve the original signal amplitude and outputted at the original 
recorded sampling rate at 30 kHz. 
Sending known pre-recorded data through the device allowed for verification that the 
output data was correct. Additionally, whereas the general spike waveform is known and can be 
visually detected in the signal, the spiking band waveform is not and offline comparison with the 
exact same data is critical. In practice, the system will not need to send neural data off the device. 
A motor command will be decoded from the data and sent over the NNP system to be transformed 
into a stimulation pattern. However, for testing purposes, the recorded data was sent to a computer 
for analyses and validation of the module.  In 2 kSps mode, at the end of each bin period, the 
module computes the average for each channel. At the completion of either 2 kSps or raw 30 kSps 
data, the device passes all the recorded data to an external computer through USART, using a 
Future Technology Devices International (FTDI) chip as a USB interface for analyses and 
validation. Neural action potentials are visible when in single channel mode and the spiking band 
power is visible in multichannel mode and are later compared to PC-processed data. 
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In Vivo Recordings 
Data was also recorded by the module in vivo directly from a monkey. During these 
recordings, the monkey sat in a primate chair (Crist Instruments) with his head restrained not 
performing any task. A Cereport breakout connector was used to connect the array pedestal to the 
module through the Samtec connectors. Neural data was recorded directly through the device and 
sent to an external computer using an FTDI chip as a USB interface, shown in figure 2.6 (B). 
 
Figure 2.6. Experimental Setup.  (A) While the monkey performs the finger flexion task, broadband 
neural data is recorded through the Cerebus and saved on a computer. The offline data is later replayed 
through the module using a National Instruments DAQ card. (B) While the monkey sits still, neural data 
is recorded through the device and sent to a computer. 
 
2.4 Results 
2.4.1 Device Validation 
Figure 2.3 shows the final device, 1 cm x 4 cm for each of 3 panels. Currently this prototype 
does not include the flexible connections between panels, but only 16 lines run between the panels, 
such that the same layout could be fabricated in a flex design. An example of this flex design is 
illustrated in figure 2.4. This design was tested extensively on the benchtop and with animals as 
described below. 
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Pre-recorded Data 
First, we verified that signals were passing reliably through the Intan amplifiers to the 
microcontroller. During these tests, the module was powered by a DC regulated power supply at 
3.3 V, bypassing the built-in power conditioning circuitry. The amplifiers were configured to filter 
a passband of 0.1- 7,500 Hz and were sampled at 32 kSps. These settings enabled testing of the 
wideband performance of the device. The sampled data was transmitted to an external computer 
for storage and processing. In single channel mode, signals were introduced and verified at 
individual inputs on each bioamplifier. Individual channel investigation was necessary, as the 
 
Figure 2.7. Single channel data recorded through the device, sampled at 32 kSps. (A) 1 kHz sine wave. 
(B) Simulated neural data from neural signal generator (Blackrock Microsystems). (C) Pre-recorded 
neural data from rhesus macaque. 
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system was designed to process data at much lower rates and the microcontroller cannot handle 
the throughput necessary for all 96 channels at 32 kSps. However, the spiking band of all 96 
channels can be processed in multichannel mode at 2ksps. Figure 2.7 shows the results of testing 
in single channel mode, where details of the incoming signal can be easily viewed. First, a 1 kHz 
sine wave was introduced to the amplifier input and the sampled output at 32 kSps, shown in figure 
2.7 (A). The device was next validated with simulated neural signals from a neural signal generator 
(Blackrock Microsystems). Figure 2.7 (B) shows an example recording where spikes were clearly 
visible. Figure 2.7 (C) shows an example using real, prerecorded neural data at 32 kSps from a 
rhesus macaque performing finger flexion tasks. All channels looked and performed similarly.  
 
In Vivo Data 
For consideration as a future clinical system, the device also needs to be able to handle the 
noise and impedances associated with live recordings. We tested this by recording directly from a 
Utah array in a nonhuman primate. Figure 2.8 shows an example recording from six channels 
showing clear single unit activity, manually picked out. Data recorded through the device had an 
RMS noise of 3.2 µVRMS which is comparable to that of the Cerebus at 2.1 µVRMS. These 
channels were recorded separately, as this device is not designed to process 30 kSps data on all 96 
channels, as the MCU cannot sample that fast and it would consume too much power for the overall 
system. However, these results show it is possible to record one channel of broadband data for 
basic science purposes, or for calibration purposes in a clinical system.  
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Figure 2.8. Single units recorded in vivo through the device. Each channel was recorded individually. 
 
2.4.2 Spiking Band Power Validation 
Module Outputs Spiking Band Power 
Next, we tested the intended usage mode where all 96 channels are recorded at once, using 
a spiking band filter similar to that used by Stark and Abeles (Stark & Abeles, 2007). The device 
was configured to filter inputs between 300-1,000 Hz, which we previously showed to enable 
decoding with 95% of the performance associated with decoding threshold crossing events 
(Irwin…Bullard et al., 2016). The microcontroller sampled all 96 channels at 2.17 kSps and 
transmitted the averaged absolute value of the signal after 128 samples (~58 ms bins) to a computer 
for analysis. This mode was tested with raw pre-recorded neural data from Utah arrays, played 
back through the device, such that it could be compared in multiple ways. We performed the same 
processes used on the device offline in Matlab. The same broadband dataset used to playback 
through the device was filtered between 300-1,000 Hz with a 2nd order Butterworth filter, 
downsampled to 2 kSps, and the absolute value was averaged over 58 ms to estimate the mean 
signal power on each channel. The output from the pre-recorded data played back through the 
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device was compared to the offline processed result. The offline Matlab results and the device 
output are shown in figure 2.9, where the two signals matched closely, with a Pearson’s correlation 
coefficient of 0.9607.  
 
Figure 2.9. Spiking band power validation. Power calculated from 2 kSps data offline compared to data 
output from the device on a single channel. 
 
Comparing Spiking Band to Spiking Rate 
In Irwin et al, we showed that low bandwidth intracortical data could be used to predict a 
monkey’s continuous finger position. In comparison to decodes using spike counts acquired from 
high bandwidth data, performance drops by only 4.9% (Irwin…Bullard et al., 2016). One 
explanation of this is that signal power within 300-1,000Hz represents the firing rate of neurons 
on a particular channel, leading to a similar decode performance. To further test whether the 
spiking band power results from actual spikes, we compared the spiking band power output from 
the device to the firing rate obtained from thresholding the broadband data, as used in many online 
BMI experiments. Datasets were chosen for the two monkeys (N, W) on days with similar tasks 
and performance. Within these datasets, the channels with visualized single unit waveforms were 
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used in the analyses. Using Matlab, the mean firing rate was calculated in 100 ms windows. The 
same broadband datasets were replayed through our device, which returned the 2 kSps spiking 
band power, which was then averaged offline in Matlab with the same 100 ms window size. We 
compared the traces of mean firing rate and mean power over multiple channels and used the 
correlation coefficient to assess their agreement. This yielded a mean correlation of R = 0.8656 in 
Monkey N and R = 0.8027 in Monkey W. The high correlation between firing rate and signal 
power suggests that the spiking band is related to actual spiking events and is not only capturing 
local field potentials (LFP). The channel with the best performance in each monkey is shown in 
figure 2.10 (A). Histograms of per-channel correlations are shown in figure 2.10 (B). The varying 
distribution of correlation across the channels and different animals can be attributed to the 
variance of the amplitude and activity frequency of the neurons during the defined time window. 
 
Figure 2.10. (A) Comparison of mean spiking band power from the device normalized to the maximum 
power and firing rate calculated offline normalized to the maximum firing rate over 100 ms windows for 
the best single channel. (B) Histograms of the correlation coefficients for all channels in the dataset. 
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2.4.3 Power Consumption 
In each mode, power was calculated by measuring the total system current through a 
jumper. Most of the power was consumed by the three Intan RHD2132s and the Atmel 
AT32UC3C2256C microcontroller. With all power saving techniques in use, system power was 
measured at 33.6 mW while sampling 96 channels at 2 kSps, configured to filter between 300-
1000 Hz. As a comparison, the power required to transmit a single channel, filtered between 0.1- 
7,500 Hz at 30 kSps, using our system was 31.2 mW. To transmit a single channel at 2 kSps, only 
22.1mW were needed. The primary single-channel power savings came from the reduced filter 
bandwidth and sampling rate. While it would not be practical to stream 96 channels at 30 kSps, it 
is possible to view single unit waveforms one at a time using this approach. 
To achieve this lower power consumption and ease the burden on the overall system power 
management of the NNP, we used several features of the MCU to decrease overall power 
consumption, summarized in table 2.2. First, we enabled the DMA which allowed the device to 
control sampling from the amplifiers without having to wake up the processor from a low-power 
sleep mode. The DMA was more efficient at sampling and was necessary to acquire data from all 
96 channels at 2 kSps. The core alone could manage a maximum of 1 kHz while at the full clock 
rate, while the DMA could still exceed the sampling rate even after a major reduction in clock 
speed. System power was measured at 45.3 mW while transmitting all 96 channels at 2 kSps using 
the DMA. Next, we disabled all unused peripherals on the MCU. Using the DMA and turning off 
unused peripherals decreased power consumption by 11% to 40.0 mW. Finally, the processor core 
was configured to spend most of its time in IDLE sleep mode. Since the DMA automates sampling, 
the MCU core only needs to wake up every 64 ms to bin the data. With all these power saving 
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techniques enabled, system power was measured at 33.6 mW, a 16% reduction from when the 
CPU is fully awake, and a 25% reduction overall.  
In addition to the techniques discussed above, reducing the number of channels transmitted 
could also reduce the amount of power consumed by the device. Selectively using only the well-
tuned channels has been shown to positively contribute to the decode performance (Wahnoun, He, 
& Helms Tillery, 2006). This concept of channel masking allows us to record from only a subset 
of channels and retain the decode performance. We simulated this by recording from only a portion 
of the channels evenly distributed across all three amplifiers. Transmitting all 96 channels in the 
lowest power mode required 33.6 mW. Disabling roughly a third of the channels to transmit only 
63 channels consumed 31.4 mW. Disabling approximately two thirds of the channels allowed a 
50% reduction to the system clock speed, where transmitting 33 channels of data required 26.7 
mW. 
 
Additionally, for completeness, we tested functionality of the device’s CAN network 
interface and power conditioning circuitry by connecting it exclusively to an NNP power module 
and validated that the devices could communicate. System power of the neural recording module 
was measured at 43.6 mA, while being powered by the NNP power module at 3.98 V, and 
recording and binning all 96 channels, using the DMA as described above.    
 
 
# Channels Power Mode System Power  
1 
1 
96  
30ksps 
2ksps 
2ksps DMA sampling + CPU awake 
31.2 mW 
22.1 mW 
45.3 mW 
96 2ksps DMA sampling + Disabled Peripherals + CPU awake 40.0 mW 
96 
 
 
 
2ksps DMA sampling + Disabled Peripherals + CPU asleep 33.6 mW 
 
 
Table 2.2. Power Saving Techniques 
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2.5 Discussion 
We have designed a 96-channel neural recording module prototype that can be used with 
the NNP system. The neural recording module was designed using entirely off-the-shelf 
components and all active circuitry fit within 1 cm x 4 cm panels. While the current NNP sensor 
modules have a 1 cm x 3 cm hermetically sealed enclosure, increasing the length by 1 cm is not 
outside of the capabilities of the manufacturer and does not compromise the design. Our device 
extracts signal power in a narrow frequency band, which allows us to sample at a low rate of 2 
kSps. We demonstrated the neural recording module consumed 33.6 mW when transmitting all 96 
channels at 2 kSps using all power saving techniques. We have not yet implemented decoding and 
full communication over the CAN network and expect these functions to draw some additional 
power. However, we have tested the functionality of the CAN network while the device was being 
powered exclusively by the NNP power module and found our device’s power consumption to be 
similar to that of existing NNP permitting normal function of other modules (power, actuator, and 
sensor). Most demonstrations of wireless neural recording devices have been done using >50 Mbps 
of digitized voltage traces, which is far beyond the specifications of implantable devices. The 
ability to sample at a lower rate tremendously decreases the size of the data and will be key in 
communication with the NNP network, which has a bandwidth of 100 kbps. Our current design 
uses three 8 mm x 8 mm 32-channel Intan bioamplifiers, which is a limiting factor in PCB length 
and power consumption of the module. However, the BGA packaging of the next generation 9 mm 
x 7 mm 64-channel Intan bioamplifier offers the possibility of improving our current design by 
decreasing the number of chips from 3 to 2. This will dramatically reduce the size of our board 
without any major design changes, bringing us closer to the 1 cm x 3 cm package of the existing 
NNP modules. Each individual bioamplifier consumes some baseline power, so the reduction in 
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the number of Intan bioamplifiers required will eliminate a portion of this power consumed and 
enable significant power savings. In addition, if the design option were available to reduce the 3.3 
V supply voltage required for the Intan bioamplifiers, that would lead to further reduction of the 
overall power consumption of the device. 
Additionally, channel masking provides opportunities to save even more power. Wahnoun 
et al. found that less than 70% of recorded neurons are well tuned to movement direction and that 
some of these neurons actually decrease decoding performance. Selecting the best 20 neurons to 
control their neuroprosthetic system performed better than using all neurons (Wahnoun et al., 
2006). Reducing the number of channels transmitted will reduce the computational load and result 
in a decrease in overall power consumption and prolonged battery life. 
 While it enables dramatic power savings, there are still open questions about exactly where 
the "spiking-band" signal is coming from. This is important in order to understand how far the 
approach can go. Is it a local signal directly reflective of spikes? Or is it broader LFP like 
electrocorticography (ECoG), which can also contain some movement information (Chestek et al., 
2011; Flint, Scheid, Wright, Solla, & Slutzky, 2016)? We have previously demonstrated that we 
can drop the upper frequency of the spiking band filter from 6 kHz (Stark & Abeles, 2007) to 1 
kHz with only a 4.9% decrease in performance (Irwin…Bullard et al., 2016). Here, we have shown 
that the power in the spiking band is highly correlated with the firing rate of threshold crossing 
spiking rate of the input high bandwidth data. This suggests that spiking band power may be most 
reflective of the spikes themselves. This is not surprising since action potentials have a 1-1.5 ms 
sinusoidal-like waveform, and we filtered between 300-1,000 Hz. Spike amplitude also falls off 
quickly, theoretically as the reciprocal of the distance from the electrode (Holt & Koch, 1999; 
Moffitt & McIntyre, 2005), which makes it possible that the spiking band signal is fairly local. 
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Based on the frequency components it is likely that the spiking band contains both localized spikes 
and broader LFP. This may be a benefit to the traditional use of thresholded spikes because the 
spiking band may be used to still interpret useful data from channels that over time no longer have 
good quality spikes.  
Custom ASIC designs have been presented to be smaller in size and consume less power, 
however, the noise, impedance, and large transient voltages that are present in live data within real 
world settings make it difficult to also achieve signal integrity and stability under these conditions. 
With academic bioamplifiers progressing to a more commercial platform, we can record live stable 
signals under very realistic parameters using off the shelf components, as seen with this device. 
Overall, using the signal processing techniques described here, custom ASIC-free designs may 
have crossed the threshold of viability for multi-channel neural recording. 
 At the moment, percutaneous wires and power are arguably the most limiting factors in 
translating BMI systems to clinical use. The best devices run for only a few hours on a battery or 
rely on wearable components (Borton et al., 2013). So long as this is true, spiking band devices 
may offer the fastest path to clinical viability. In the future, should the number of electrodes 
become more of a limitation than the power, it may make more sense to extract the maximum 
amount of information from each electrode by extracting single unit timing. Currently, however, 
several hundred electrodes can be implanted percutaneously in humans (T Aflalo et al., 2015; 
Collinger et al., 2013a; Gilja et al., 2015b; Hochberg et al., 2012a), without being able to process 
even 100 of those channels with implantable electronics. 
2.6 Conclusion 
This device was designed to acquire data at configurable bandwidths, sampling rates, and 
channel counts using the Intan bioamplifiers which could allow it to be used for applications 
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outside of Utah array recording. The freedom to choose the filter parameters supports a variety of 
neural signal modalities, such as ECoG and EMG. While there are many interesting implantable 
devices in development for EMG (Baker, Scheme, Englehart, Hutchinson, & Greger, 2010; Troyk, 
DeMichele, Kerns, & Weir, 2007) as well as wireless ECoG for epilepsy (Mestais et al., 2015; 
Vansteensel et al., 2010), these devices would serve relatively small markets by themselves. 
However, the concept behind the NNP is that existing modules can be applied to multiple 
applications and markets, as the stimulation and power modules can be used for a brain-controlled 
FES device theoretically proposed in this work. The specifications in this paper, representing the 
first attempt to combine designs from different groups, can be used as a guide to develop further 
application specific modules. While representing a departure from traditional medical devices, the 
reuse of components and circuitry from the existing NNP platform may dramatically accelerate 
the overall process to a clinically viable system. 
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Chapter 3 
Estimating Risk for Future Intracranial Neuroprosthetic Devices: A systematic review of 
hardware complications in clinical deep brain stimulation and experimental human 
intracortical arrays 
 
A version of this chapter has been submitted and is currently under peer review to the Journal of 
Neuromodulation. 
 
Bullard, A. J., Hutchison, B. C., Lee, J., Chestek, C. A., Parag, P. G. “Estimating Risk for Future 
Intracranial Modular Neuroprosthetic Devices: A systematic review of hardware complications in 
clinical deep brain stimulation and experimental human intracortical arrays.” Neuromodulation. 
 
3.1 Abstract 
A new age of neuromodulation is emerging: one of restorative neuroengineering and 
neuroprosthetics. As novel device systems move towards regulatory evaluation and clinical trials, 
a critical need arises for evidence-based identification of potential sources of hardware-related 
complications and advance estimation of safety risks to facilitate clinical trial design and fully 
inform patient consent. The objective of this systematic review is to provide a detailed safety 
analysis for future intracranial, fully implanted, modular neuroprosthetic systems. To achieve this 
aim, we conducted an evidence-based analysis of hardware complications for the most established 
clinical intracranial modular system, deep brain stimulation (DBS), as well as the most widely 
used intracranial human experimental system, the silicon-based (Utah) array. Of 2,328 
publications identified, 240 articles met the inclusion criteria and were reviewed for DBS hardware 
complications. The most reported adverse events were infection (4.57%), internal pulse generator 
malfunction (3.25%), hemorrhage (2.86%), lead migration (2.58%), lead fracture (2.56%), skin 
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erosion (2.22%), and extension cable malfunction (1.63%). Of 433 publications identified, 76 
articles met the inclusion criteria and were reviewed for Utah array complications.  Of 48 human
subjects implanted with the Utah array, 18 have chronic implants. Few specific complications are 
described in the literature, hence implant duration served as a lower bound for complication-free 
operation. The longest reported duration of a person with a Utah array implant is 1,975 days (~5.4 
years). Through systematic review of the clinical and human-trial literature, our study provides the 
most comprehensive safety review to date of DBS hardware and human neuroprosthetic research 
using the Utah array. The evidence-based analysis serves as an important reference for 
investigators seeking to meet regulatory requirements and to design clinical trials for future 
intracranial, fully implanted, modular neuroprosthetic systems.  
 
3.2 Introduction 
A new age of neuromodulation is emerging. Established open-loop neuromodulation 
systems treat a broad range of neurological network disorders, including Parkinson disease, tremor, 
dystonia, obsessive-compulsive disorder, epilepsy and pain. A newly approved closed-loop device 
provides responsive neural control of epilepsy. A growing body of literature suggests promise for 
neuromodulation to treat intractable depression and enhance recovery from spinal-cord injury. 
Experimental neuroprosthetic systems incorporate intracortical silicon-based arrays and 
networked sensing and stimulation modules to allow real-time neuroprosthetic control. As 
technology advances and the number of modular systems grow, a need arises to anticipate the 
potential safety features and shortcomings of future neuroprosthetic systems. Such analysis, based 
upon all available evidence, is prerequisite to satisfying regulatory requirements, formulating 
clinical-trial design and oversight, and fully informing patient consent.  
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The primary aim of this systematic review is to provide a detailed safety analysis to inform 
future intracranial, fully implanted and modular neuroprosthetic systems. To accomplish this aim, 
we examine the safety profiles of the most widespread intracranial clinical system, deep brain 
stimulation, as well as the most widespread intracranial human experimental system, the silicon-
based (Utah) array, to identify safety considerations inherent to emerging modular neuroprosthetic 
systems and to derive the most reliable advance safety estimates possible for likely future 
neuroprosthetic systems. Our comprehensive and systematic review of the safety literature for deep 
brain stimulation and human trials of the Utah array provides greater detail and scope than many 
earlier reviews by encompassing all indications for DBS and focusing upon the structural 
components of the DBS system. This review thereby achieves a secondary aim as the most 
comprehensive evaluation of DBS hardware safety to date. Detailed safety evaluation of 
experimental systems, such as the Utah array, has been difficult due to the dearth of complications 
reported in the literature, which focuses upon scientific and technological advances. However, 
indirect indicators exist. For example, we can estimate the duration of complication-free Utah array 
operation from reported periods of implant longevity in the literature. As a result, in addition to 
evaluating the potential safety of future modular intracranial device systems, this review also 
achieves an additional secondary goal of providing the most comprehensive safety and longevity 
review to date of human neuroprosthetic research using the Utah array. 
Currently FDA-approved chronically implanted intracranial neuromodulation systems 
include deep brain stimulation (DBS) and responsive neurostimulation (RNS). DBS has been used 
for decades to treat movement disorders (L. Ackermans et al., 2011; Rodríguez Cruz et al., 2016; 
Weaver et al., 2009) and, more recently, to treat neuropsychiatric disorders and epilepsy (Abreu et 
al., 2017b; S. H. Kim et al., 2017b; Ooms et al., 2014). DBS systems are modular, consisting of a 
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multi-contact lead, an internal pulse generator (IPG), and an extension cable. The multi-contact 
lead is a depth electrode, typically 28 or 40 cm long, inserted into an intracranial target structure 
through a burr hole in the skull. The lead is secured at the skull entry point via a burr hole cover. 
The IPG is typically placed subcutaneously in the chest region. The extension cable connects the 
two via subcutaneous tunneling along the neck. As a related example, the responsive 
neurostimulation system for epilepsy (RNS, NeuroPace Inc.) is similarly modular, consisting of 
cortical strip or depth leads connected to a cranially-implantable neurostimulator unit (Heck et al., 
2014).  
To monitor and record brain electrical activity for neuroprosthetic applications, the 
commercially available Utah array (NeuroPort, Blackrock Microsystems, Inc.) is FDA approved 
for human implantation up to 30 days, or longer with an investigational device exemption. The 
NeuroPort Array consists of a 4.0 mm x 4.0 mm silicon-based microelectrode (Utah) array with 
96 electrodes, extending 1.0 to 1.5 mm, and a wire bundle connecting the array to a pedestal (figure 
1). The pedestal penetrates the skin to provide electrical connectivity. A cable carries signals from 
the pedestal to front-end amplifiers and, ultimately, to a computer-based signal acquisition system 
for recording and decoding (Hochberg et al., 2006; Truccolo, Friehs, Donoghue, & Hochberg, 
2008). Currently, the major limitation of the NeuroPort system is that tethering the pedestal to 
external hardware impedes mobility, constraining array use to laboratory settings. In addition, the 
transcutaneous pedestal violates the barrier integrity of the skin, potentially raising the risk of 
infection. Any clinically adopted neuroprosthetic system will require the Utah array to be 
connected to a fully implanted modular actuator system with the ability to record and respond to 
stimuli, similar to closed-loop DBS or RNS.  
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An example of such a system is the Networked Neural Prosthesis (NNP). The NNP is a 
fully implantable, modular functional electrical stimulation (FES) system which, in conjunction 
with implanted Utah arrays, could form a fully-implanted future neuroprosthetic system. The 
current NNP consists of a sensor module responsible for recording myoelectric activity, an actuator 
module responsible for providing intramuscular stimulation, and a power module which functions 
as the central power for all modules. The modules are connected by a serial cable, allowing 
communication across modules. Combinations of these modules can be distributed around the 
body to assist in a variety of functions lost by individuals due to spinal cord injury (US 7,260,436 
B2, 2007; Smith et al., 2005). The current-version NNP only records residual myoelectric activity, 
but because the system was designed to accept additional modules, it may be possible to add a 
neural recording module to record directly from the brain and facilitate cortical-controlled FES. 
Hence, a combined Utah Array-NNP system becomes a useful exemplar system for safety analysis. 
An overview of the exemplar, prototypical fully implantable, modular, neuromodulation system 
that can be used for FES is shown in figure 3.1 (B).  
Our primary aim is to provide a detailed safety analysis for such a future intracranial, fully 
implanted and modular neuroprosthetic system. To understand potential hardware complications 
for such emerging systems, we have performed a systematic review focused on the hardware 
mechanisms of DBS failure as well as longevity or safety of the Utah array in humans. DBS is a 
well-established, fully implantable system that is similarly modular to our exemplar prototypical 
neuroprosthetic system. Hence, major safety concerns and potential failure modes of the Utah 
Array-NNP system are hypothesized to be similar to those documented in DBS and Utah Array. 
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Figure 3.1. A) Overview of the standard brain machine interfaces set up. An electrode is implanted in the 
brain and percutaneous connections are made between the patient and a series of computers. This 
particular example is of brain-controlled FES (Ajiboye, 2017). B) An example of a potential future brain 
machine interface set up using a modular network. An electrode is implanted in the brain and connected 
to an implantable module for processing instead of a series of computers. This portrays the potential for a 
fully implantable brain-controlled FES system using the NNP. 
 
3.3 Methods 
3.3.1 Search Strategy 
A systematic review was conducted to identify the relevant literature on hardware 
complications of DBS, by searching the electronic databases: Pubmed, ClincalTrials.gov, Scopus, 
and Cochrane’s Library. The search was broken down into two concepts; device and risks. A 
comprehensive list of keywords was generated to capture all synonyms of DBS and risks, including 
both general terms and potential risks specific to DBS. All device related keywords were grouped 
together by an OR operator and the same was done for the risk keywords. The device and risk 
groups were then merged with the AND operator to identify all articles with mention of DBS and  
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some form of risk or complication in the title or abstract (table 3.1). 
 
Table 3.1. Keywords and Search Structure for Hardware Complications in DBS 
 
A similar approach was taken to identify all articles including the use of the Utah array in 
humans in the title or abstract. The search was again separated into two concepts: device and 
patient, where a comprehensive list of all synonyms describing Utah arrays and humans was 
generated. Each separate concept group was combined through the OR operator and then together 
with the AND operator. In addition, a list of known principal investigators who have conducted 
experiments with humans implanted with Utah arrays were identified. This was incorporated at 
the end with the AND operator to help refine the search results (table 3.2). 
 
Table 3.2. Keywords and Search Structure for Utah Arrays in Humans 
Utah Array Synonyms Human Synonyms Senior Authors 
96 channel microelectrode array*, 
96 channels electrode array*, 
microelectrode array*, intracortical 
microelectrode array*, intracortical 
brain computer interface*, 
Neuroport array* 
Human, subject*, patient*, 
tetraplegic*, quadriplegic*, person, 
people 
Donoghue, Hochberg, Kirsch, 
Henderson, Shenoy, Greger, 
Normann, House, Cash, Jang, 
Zaghloul, Salas, Andersen, 
Schwartz, Rezai, Collinger, 
Schevon, Truccolo 
[Utah array OR Utah array synonym…] AND [human OR human synonyms…] AND [senior author OR senior 
author…] 
(*) symbol at the end of a word to include other terms that begin with the root word (i.e. –ing, -s). 
 
DBS Synonyms Risk Synonyms 
Deep brain stimulation, Thalamic stimulation 
Hematoma, bleed*, “short circuit”, fracture, breakage, 
migration, infection, erosion, revision, risk, safety, 
adverse event*, “adverse effects”, complication*, 
hardware failure 
[DBS OR DBS synonym…] AND [ risk OR risk synonym…] 
(*) symbol at the end of a word to include other terms that begin with the root word (i.e. –ing, -s). 
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3.3.2 Study Selection 
The search results were critiqued through a two-reviewer process. Each reviewer 
independently read the title and abstract of articles to screen for relevance. They were classified as 
either possibly relevant or clearly irrelevant. Articles deemed as clearly irrelevant by both 
reviewers were immediately excluded, and articles classified as possibly relevant by both 
reviewers were immediately included. The articles where the reviewers disagreed were reviewed 
again, discussed, and then resolved.  
Predefined inclusion and exclusion criteria were created to further refine our search results 
to include only the papers within the scope of the review, shown in figure 3.2. Selected articles 
were required to have clinical data from a primary study, report on bleeding, infection, or hardware 
complications related to DBS, and include a quantification of risk. Articles not reporting data on 
hardware complications, and articles reporting data solely on revision procedures were excluded, 
as well as case studies, review articles, and editorial letters. Only full-length articles in English 
that met all criteria were eligible for inclusion. Two reviewers (AB and JL) independently read the 
full-length articles and assessed against the inclusion criteria. Articles that met all criteria 
according to both reviewers were included in this review. Articles that both reviewers agreed did 
not meet one or more of the criteria were excluded. The remaining articles where the reviewers 
disagreed were reviewed again, discussed, and then resolved. 
3.3.3 Data Extraction 
To avoid extraction errors, two reviewers independently extracted data from the eligible 
articles and any discrepancies were discussed and resolved. Infection, hemorrhage, skin erosion, 
and hardware failures related to malfunctions of the extension cable and IPG, and fracture or 
migration of the DBS electrode were the primary complications focused on in this review. For 
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each eligible article the following data were extracted about the adverse event: incidence rate, 
location, the time of occurrence post initial surgery, if additional surgery was required, and if it 
resulted in a total explant of the system. 
 
Figure 3.2. Flow diagram of the study selection for DBS hardware complications. 
 
3.4 Results 
3.4.1 DBS Search Results and Study Characteristics 
Our initial database search yielded 2,328 articles that contained our keywords and MeSH 
terms in either the title or abstract. After screening titles and abstracts, 479 potentially relevant 
articles were identified, and the full text was assessed against the inclusion criteria. Finally, 240 
articles were chosen to be included in this meta-analyses (Abode-Iyamah et al., 2018; Abreu et al., 
2017a; Linda Ackermans et al., 2011; Air, Ostrem, Sanger, & Starr, 2011; Akram, Limousin, 
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Hyam, Hariz, & Zrinzo, 2015; Alex Mohit, Samii, Slimp, Grady, & Goodkin, 2004; Allert et al., 
2018; Alomar, Mullin, Smithason, & Gonzalez-Martinez, 2018; Alterman et al., 2007; Amirnovin, 
Williams, Cosgrove, & Eskandar, 2006; Ashkan, Alamri, & Ughratdar, 2015; Aviles-Olmos et al., 
2014; Baizabal-Carvallo, Kagnoff, Jimenez-Shahed, Fekete, & Jankovic, 2014; Baizabal Carvallo 
et al., 2012; Ben-Haim, Asaad, Gale, & Eskandar, 2009; Bergey et al., 2015; Bergfeld et al., 2016; 
Beric et al., 2001; R. Bhatia et al., 2011; S. Bhatia, Oh, Whiting, Quigley, & Whiting, 2008; S. 
Bhatia, Zhang, Oh, Angle, & Whiting, 2010; Binder, Rau, & Starr, 2005, 2003; Bjerknes, 
Skogseid, Sæhle, Dietrichs, & Toft, 2014; P Blomstedt & Hariz, 2005; Patric Blomstedt & Hariz, 
2006; Bourne, Conrad, Konrad, Neimat, & Davis, 2012; Boviatsis, Stavrinou, Themistocleous, 
Kouyialis, & Sakas, 2010; Burdick, Fernandez, et al., 2010; Burdick, Okun, et al., 2010; Cersosimo 
et al., 2008; Chan et al., 2009; Chang et al., 2011; D. Charles et al., 2014; P. D. Charles et al., 
2012; Chen et al., 2018; Chen, Mirzadeh, Lambert, et al., 2017; Chen, Mirzadeh, Chapple, 
Lambert, & Ponce, 2017; Chiou, 2016; Chou et al., 2007; Chowdhury, Wilkinson, & Cappellani, 
2017; Chui, Alimiri, Parrent, & Craen, 2018; Cif et al., 2012; Constantoyannis, Berk, Honey, 
Mendez, & Brownstone, 2005; Coubes et al., 2002; Cury et al., 2017; Dafsari et al., 2018; de 
Quintana-Schmidt et al., 2014; Deep-Brain Stimulation for Parkinson’s Disease Study Group et 
al., 2001; Delavallée, Abu-Serieh, de Tourchaninoff, & Raftopoulos, 2008; Delavallée, Delaunois, 
Ruwet, Jeanjean, & Raftopoulos, 2016; DeLong et al., 2014; Deuschl et al., 2006; Diamond, 
Shahed, Azher, Dat-Vuong, & Jankovic, 2006; Dlouhy, Reddy, Dahdaleh, & Greenlee, 2012; 
Doshi, 2011; Dowd, Pourfar, & Mogilner, 2018; Downes et al., 2016; Egidi et al., 2007; Esselink 
et al., 2004; S. M. Falowski & Bakay, 2016, 2016; S. M. Falowski, Ooi, & Bakay, 2015; S. 
Falowski, Ooi, Smith, Verhargen Metman, & Bakay, 2012; Fenoy & Simpson, 2012, 2014; 
Fernández-Pajarín et al., 2017; Fernández, Alvarez Vega, Antuña Ramos, Fernández González, & 
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Lozano Aragoneses, 2010; Fily et al., 2011; Follett et al., 2010; Frizon et al., 2017; Fytagoridis & 
Blomstedt, 2010; Geller et al., 2017; Gervais-Bernard et al., 2009; Gocmen et al., 2014; 
Gologorsky et al., 2011; Goodman, 2006; Gorgulho et al., 2009; Gorgulho, De Salles, Frighetto, 
& Behnke, 2005; Greenberg et al., 2006; Gubler et al., 2017; Guridi, Rodriguez-Oroz, Alegre, & 
Obeso, 2012; Hardaway, Raslan, & Burchiel, 2018; Harries et al., 2012; Henssen et al., 2018; 
Higuchi et al., 2016; Hilliard et al., 2016; Holslag et al., 2018; Holtzheimer et al., 2017; K. Hu, 
Moses, Hutter, & Williams, 2017; X. Hu et al., 2010; Iansek, Rosenfeld, & Huxham, 2002; Isaias, 
Alterman, & Tagliati, 2009; Janson, Maxwell, Gupte, & Abosch, 2010; Jobst et al., 2017; Joint, 
Nandi, Parkin, Gregory, & Aziz, 2002; Kahn et al., 2012; Kaminska et al., 2012, 2017; Kawakami 
et al., 2005; Keen, Przekop, Olaya, Zouros, & Hsu, 2014; Kefalopoulou et al., 2015; Khatib et al., 
2008; M. Kim et al., 2017; M. S. Kim, Jeong, Ryu, Choi, & Chung, 2017; S. H. Kim et al., 2017a; 
Klein et al., 2017; Kochanski, Nazari, & Sani, 2018; Koller et al., 1997; Kondziolka, Whiting, 
Germanwala, & Oh, 2002; Koy et al., 2017; Kramer, Halpern, Danish, Jaggi, & Baltuch, 2012; 
Krause et al., 2016; Kumar et al., 2000; Kupsch et al., 2006; Landi et al., 2003; J. Y. K. Lee & 
Kondziolka, 2005; S.-W. Lee et al., 2014; Lefebvre et al., 2017; Lempka et al., 2017; Leone, 
Franzini, Proietti Cecchini, & Bussone, 2013; Levi, Carrabba, Rampini, & Locatelli, 2015; Levy, 
Lamb, & Adams, 1987; Lezcano et al., 2016; Li et al., 2013, 2017, Lim et al., n.d., 2007; Limousin, 
Speelman, Gielen, & Janssens, 1999; Linhares, Carvalho, & Vaz, 2013; Lipsman et al., 2017; 
Loher et al., 2002; Lozano et al., 2016; K E Lyons, Koller, Wilkinson, & Pahwa, 2001; Kelly E 
Lyons, Wilkinson, Overman, & Pahwa, 2004; Maldonado et al., 2009; Mandat et al., n.d.; Martin 
et al., 2017; Martinez-Ramirez et al., 2018; J H Mehrkens et al., 2009; Jan Hinnerk Mehrkens, 
Borggraefe, Feddersen, Heinen, & Bötzel, 2010; Mendes Martins et al., 2012; Meoni et al., 2017; 
Merola et al., 2017; Messina, Rizzi, Dones, & Franzini, 2014; J. P. Miller, Acar, & Burchiel, 2009; 
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P. M. Miller & Gross, 2009; S. Miller et al., 2016; Morishita et al., 2017; Moro et al., 2010; 
Motlagh et al., 2013; Movement Disorder Group et al., 2014; Nahas et al., 2010; Nazzaro et al., 
2010; Nunta-Aree, Sitthinamsuwan, Boonyapisit, & Pisarnpong, 2010; O’Sullivan & Pell, 2009; 
Odekerken et al., 2013; Oh, Abosch, Kim, Lang, & Lozano, 2002; Okun et al., 2012; Oliveria et 
al., 2017; J L Ostrem et al., 2011; Jill L Ostrem et al., 2013, 2016, 2017; Oyama et al., 2011; Pahwa 
et al., 1999, 2001; Paluzzi, Belli, Bain, Liu, & Aziz, 2006; Panov et al., 2013; C. K. Park, Jung, 
Kim, & Chang, 2017; J. H. Park, Chung, Lee, & Jeon, 2011; Y. S. Park et al., 2011; D. M. Patel 
et al., 2015; Peña et al., 2008; Pepper et al., 2013; Petraglia et al., 2016; Petrossian et al., 2013; 
Piacentino, Pilleri, & Bartolomei, 2011; Ponce et al., 2016; Putzke et al., 2003; Ramayya et al., 
2017; Rasouli & Kopell, 2016; Reuter, Deuschl, Falk, Mehdorn, & Witt, 2015; Rosa et al., 2017; 
Ryu et al., 2017; Sachdev et al., 2014; Salanova et al., 2015; Sansur et al., 2007; Schuurman, 
Bosch, Merkus, & Speelman, 2008; F. Seijo et al., 2014; F. J. Seijo, Alvarez-Vega, Gutierrez, 
Fdez-Glez, & Lozano, 2007; Servello, Sassi, Gaeta, Ricci, & Porta, 2011; Sillay, Larson, & Starr, 
2008; Sixel-Döring, Trenkwalder, Kappus, & Hellwig, 2010; M. Sobstyl, Kmieć, Ząbek, 
Szczałuba, & Mossakowski, 2014; M. Sobstyl, Ząbek, Dzierzęcki, Koziara, & Mossakowski, n.d.; 
M. R. Sobstyl, Ząbek, Brzuszkiewicz-Kuźmicka, & Pasterski, 2017; Solmaz et al., 2014; Son et 
al., 2012; Staudt, Pourtaheri, Lakin, Soltanian, & Miller, 2017; Stroop, Holms, Nakamura, & 
Lehrke, 2018; Sydow, Thobois, Alesch, & Speelman, 2003; Tanei et al., 2009; Temel et al., 2004; 
Terao et al., 2003; Testini et al., 2016; Themistocleous et al., 2017; Tir et al., 2007; Tolleson et al., 
2014; Tonge et al., 2015; Umemura et al., 2003, 2011; Velasco et al., 2007; Vergani et al., 2010; 
Verla et al., 2015; J. Vesper, Klostermann, Wille, Funk, & Brock, 2004; J Vesper, Chabardes, et 
al., 2002; J Vesper, Klostermann, Stockhammer, Funk, & Brock, 2002; Jan Vesper, Haak, 
Ostertag, & Nikkhah, 2007; Vidailhet et al., 2005, 2007; J Voges et al., 2006; Jürgen Voges et al., 
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2007; Volkmann et al., 2012, 2014; X. Wang et al., 2017; Welter et al., 2017; Wharen et al., 2017; 
White-Dzuro, Lake, Eli, & Neimat, 2016; White-Dzuro, Lake, & Neimat, 2017; Williams et al., 
2016; Wojtecki et al., 2015; Xiaowu et al., 2010; Yianni et al., 2004; Zhan et al., 2018; J. Zhang 
et al., 2017; K. Zhang et al., 2010; Zrinzo, Foltynie, Limousin, & Hariz, 2012; Zsigmond, Hemm-
Ode, & Wårdell, 2017) (figure 3.2). The remaining 239 articles were excluded for the following 
reasons: not DBS or related (n= 47), no quantification of risk (n=15), secondary revision 
procedures (n= 16), case studies, review articles, or editorial letters (n=145), not published in 
English (n= 5), full-length article unavailable (n=21). A total of 27,299 patients across articles 
were included in this analysis.  Notably, only 7 hardware related deaths occurred within these 
patients. All complication incidence rates are reported in table 3.3, with a breakdown of the 
reported locations of the complications. Because all articles reporting a complication, did not 
report the location of the complication the incidence rate depicts what could be accounted for.  
Table 3.3. DBS Hardware Related Adverse Events 
Complication  Incidence (%) No. of patients reported 
Infection 4.57 951 (20805) 
    IPG 
    scalp/burr hole 
    extension cable 
    lead 
20.4 
9.70 
8.24 
1.03 
2957 (14495) 
1406 (14495) 
1194 (14495) 
149 (14495) 
IPG malfunction 3.25 141 (4331) 
Hemorrhage 2.86 425 (14831) 
    intracerebral (ICH) 
    IPG 
    Extension cable 
52.9 
22.1 
2.35 
6340 (11963) 
2655 (11963) 
281 (11963) 
Lead migration 2.58 121 (4677) 
Lead fracture or failure 2.56 178 (6940) 
Skin erosion 2.22 198 (8924) 
Extension cable malfunction 1.63 84 (5145) 
Total Overall Complication 7.68 2098 (27299) 
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3.4.2 Hemorrhage 
Bleeding is always a major concern when implanting electrodes into the brain. Hemorrhage 
during and after surgery can lead to neurological damage and even death in severe cases. Of all 
the articles included in the study, 100 consisting of 14,831 patients reported on hemorrhage. The 
overall incidence rate was 2.86%. Intracerebral hemorrhage (ICH) was the most common of the 
reported occurrences (52.9%), during the duration of the implanted system.  While hemorrhage is 
most likely to occur in the brain for these procedures, it also occurred in other areas throughout 
the body as well: at the site of the IPG (4.2%) and along the extension cable (2.35%). When a 
bleed occurs, it is usually reported to happen intraoperatively or within a few days of the surgery. 
Bleeding should always be taken seriously, however the risk posed by the reported hemorrhage 
ranged in severity and the action taken to resolve it. Some hemorrhages resolve on their own 
without any external intervention, while others are more serious and may require additional 
surgeries or other procedures. For the purpose of this review, any adverse events that required an 
additional surgery were deemed as serious adverse events. In serious cases, the device is normally 
explanted. Usually bleeds that occur outside of the brain can be resolved and then hardware can 
be re-implanted.  In all the studies, there were only 6 reported deaths due to ICH (0.04%).  
 
3.4.3 Infection 
Second to bleeding, infection is often considered the next most prominent adverse event to 
be cautious of in any surgical procedure, especially when there are foreign objects introduced 
inside the body, particularly the brain. With future modular systems expected to incorporate 
multiple implantable devices around the body, this is of major concern. There were 140 articles 
consisting of 20,805 patients that reported data on infection. It was the most frequently occurring 
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adverse event, with an incidence rate 4.57%, and was the main reason for ultimate device 
explanation. There was only one reported death related to an untreated infection. The infections 
observed varied widely in their location, time of incidence relative to the initial surgery, and 
severity. Of the 4.57% of infections reported most were located at the site of the IPG (20.4%), 
followed by the connector and extension cable (8.6 %), the scalp or burr hole (9.7 %), and in the 
brain along the electrode lead (1.47 %). Of the 49 studies who reported time, infections are 
observed within the first 30 days of surgery (10.2%), however it can also occur months thereafter. 
Most cases of infections in the brain were reported early, within days, whereas infections that 
occurred around hardware outside of the brain took longer to appear. The majority of the reported 
infections were classified as severe, meaning they resulted in the patient having additional surgery. 
However, although additional surgery was required, in 35.9% of cases the infection was revised, 
and the hardware was ultimately re-implanted allowing DBS therapy to continue. Depending on 
the location of the infection only a subset of the system would be explanted and re-implanted. It 
was rare that the entire system had to be explanted and then re-implanted. However, if the infection 
was extremely severe and widespread the entire system would be permanently explanted (20.7%). 
This was typically seen in instances of infection that had tracked along the DBS electrode.  
 
3.4.4 Skin Erosion 
Skin erosion is defined here as any place where there was a breakage of the skin due to 
implanted hardware nearby.  Erosion of the skin is most commonly seen over the IPG and on the 
scalp at the site of the burr hole or the connector where the extension cable and electrode meet. 
This was reported in a total of 2.22% of cases and was very commonly associated with infection. 
In 62.6% of cases where skin erosion was reported there was also a case of infection reported near 
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the site of erosion. An additional surgery or procedure was required in 25 % of cases with skin 
erosion. Typically, wound debridement or surgical closure was used to repair skin erosion, 
however some instances required revisions and re-implantation of hardware. The more severe 
cases stemmed from erosion around the burr hole or the connector site and, where the electrode 
lead or extension cable was replaced. There were only 18 cases of skin erosion (9%) that led to the 
permanent explant of the entire system. 
3.4.5 Other Hardware Failures 
In addition to the previously mentioned hardware failures, there were also malfunctions of 
the extension cable and IPG, and fracture or migration of the DBS electrode. This includes most 
of the complications due to DBS hardware that are potentially relevant to future chronic tethered 
devices. Overall, IPG malfunction occurred 3.25% of the time, extension cable malfunction 
occurred 1.63% of the time, lead fracture occurred 2.56% of the time, and lead migration occurred 
2.58% of the time. These are typically not dangerous in and of themselves, though in a single case, 
a patient was electrically shocked due to the malfunction of the IPG(K E Lyons et al., 2001). In 
most cases however, these are complications that usually require additional routine surgeries, 
which do have their own associated risks. In 22.6 % of reported cases (including the electrical 
shock incident), they were able to revise and fix. In only 2 cases was a complete explantation 
necessary. 
 
3.4.6 Utah Array Search Results and Study Characteristics 
Our initial search identified 433 articles, which resulted in 76 articles after screening where 
humans had been implanted with the Utah array (figure 3.3). The Utah array, a 96-channel 
microelectrode array (Blackrock Microsystems), has been implanted intracortically in a total of 48  
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Figure 3.3. Flow diagram of the study selection for Utah arrays. 
 
subjects as of September 2018. This consists of patients implanted for epilepsy and other 
intraoperative opportunities where tissue would have been ablated, and patients with paralysis. 
The demographic of Utah array implants is dominated by acute cases, usually to study epilepsy, 
anesthesia, or cognition, memory or language. A smaller subset of the cases are chronic implants, 
used to study brain machine interfaces for motor control of prosthesis and stimulation for sensory 
mapping. Of the 48 people implanted with the Utah array, 30 were implanted for less than 30 days 
and 18 people were implanted chronically for more than 30 days (Tyson Aflalo et al., 2015; 
Ajiboye et al., 2017; Ajiboye, Simeral, Donoghue, Hochberg, & Kirsch, 2012b; Annetta et al., 
2018; Armenta Salas et al., 2018b; Bacher et al., 2015; Bouton et al., 2016; Brandman et al., 2018; 
Chadwick et al., 2011; Colachis et al., 2018; Collinger et al., 2013a; Downey et al., 2016, 2017; 
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Downey, Schwed, Chase, Schwartz, & Collinger, 2018; Even-Chen et al., 2018; Flesher et al., 
2016; Friedenberg et al., 2017; Gilja et al., 2015a; Hochberg et al., 2006, 2012a; Homer et al., 
2014; Jarosiewicz et al., 2013, 2015; Jitkritsadakul et al., 2017; S.-P. Kim et al., 2011, 2008; Klaes 
et al., 2015; Malik, Hochberg, Donoghue, & Brown, 2015; Masse et al., 2014; Milekovic et al., 
2018; Pandarinath et al., 2015, 2017a, 2018, Perge et al., 2013, 2014; Rutishauser et al., 2018; 
Shaikhouni, Donoghue, & Hochberg, 2013; Simeral, Kim, Black, Donoghue, & Hochberg, 2011; 
Truccolo et al., 2008; Truccolo, Hochberg, & Donoghue, 2010; Willett, Murphy, Memberg, et al., 
2017; Willett, Murphy, Young, et al., 2017; Willett, Pandarinath, et al., 2017; Wodlinger et al., 
2015b; Yang et al., 2017; Young et al., 2018; C. Y. Zhang et al., 2017). We have identified all the 
senior authors and the sites, to our knowledge, involved in studies with human implants in table 
3.4. 
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Table 3.4. Human Utah Array Implantation Sites and Senior Author Involvement 
 
The longest reported duration of a person with a Utah array implant is at least 1,975 days 
(~5.4 years), shown in figure 3.4 and table 3.5. S3, a participant in the BrainGate2 pilot clinical 
trial, was first implanted November 30, 2005, and while it has not been reported that her array has 
Chronic/Acute Site Senior Authors No. of Implants 
Chronic 
University of Pittsburgh 
Collinger JL 
2 Schwartz AB 
 Gaunt RA 
California Institute of Technology, Rancho Los 
Amigos National Rehabilitation Hospital (RLA) 
Andersen RA 3 
Brown University, Massachusetts General 
Hospital 
Donoghue JP 
12 
Hochberg LR 
Stanford University 
Henderson JM 
Shenoy KV 
Case Western Reserve University 
Kirsch RF 
Ajiboye AB 
Ohio State University 
Rezai AR 
1 
Sharma G 
Total Chronic Implants 18 
Acute 
University of Utah Health Sciences Center 
House PA 
2 
Greger B 
Normann RA 6 
Columbia University Medical Center Schevon CA 6 
Massachusetts General Hospital 
Cash SS 3 
Truccolo W 7 
National Institute of Health 
Zaghloul KA 
6 
 
Total Acute Implants 30 
Total Human Utah Array Implants 48 
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actually been explanted, it was documented that she completed her enrollment in the BrainGate2 
clinical trial (Masse et al., 2014). Of the chronic cases, there was only one report of an explanted 
Utah array in the literature. Participant S1 at the University of Pittsburgh was implanted for 987 
days and then explanted due to skin retraction around the pedestals. However, it was reported that 
there was no sign of infection. The only other mention of the safety of the Utah array implant was 
with participant EGS at California Institute of Technology. They reported that there was no device 
related adverse events to occur throughout their study (T Aflalo et al., 2015; Klaes et al., 2015). 
Table 3.5 shows the breakdown of chronic patients across different studies and the lengths of  
Table 3.5. Reported Duration of Chronic Human Implanted Utah Arrays 
Location  Participant Implantation 
Date 
Reported 
Duration 
Adverse Events 
University of 
Pittsburgh 
S1 
S2 
Feb 10,2012 
- 
987 
673 
S1 explanted due to skin 
retraction around the pedestals, 
no sign of infection 
California Institute 
of Technology 
EGS 
NS 
FG 
- 
- 
- 
630 
- 
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BrainGate2 
 
 
 
 
 
 
S1 
S3 
A1 
T1 
T2 
T5 
T6 
T7 
T8 
T9 
T10 
MN 
- 
Nov 30, 2005 
 Feb 2006 
- 
Jun 2011 
Aug 2016 
Dec 7, 2012 
Jul 30, 2013 
Dec 1, 2014 
- 
- 
Jun 2004 
90 
1975 
239 
270 
474 
70 
837 
548 
928 
- 
33 
300 
 
 
 
 
 
T7 death unrelated to research 
Ohio State 
University 
S1 - 1144  
*Reported duration is not equivalent to Utah array failure 
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reported implantation. The end of the reported duration of the implant does not mean that the Utah 
array has failed, however just the last reported published date for that participant. There have been 
a reported 9,254 of total published implant days. 
 
Figure 3.4. Length of chronic human implants reported in literature across clinical study sites. 
 
3.5 Discussion 
The safety surrounding neuromodulation technology is a critical question for both 
established and emerging systems. Hardware-related complications can result in potentially injury 
to the patient, repeated surgical procedures, and reduced clinical efficacy. In this comprehensive, 
systematic review we found that DBS had an incidence rate of 7.68% for total hardware related 
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complications. The most common adverse events were infection, followed by IPG malfunction, 
hemorrhage, lead migration, lead fracture or failure, skin erosion, and malfunction of the extension 
cable. Using this information, we are able to infer potential safety challenges that future 
intracranial, fully implanted and modular neuroprosthetic systems may face and begin the 
discussion on how to plan for and mitigate these risks when developing a clinical trial. We have 
identified the following adverse events to be potentially most salient to emerging systems: 
hemorrhage, infections, skin erosions, and malfunctions of the extension cable. 
3.5.1 Hemorrhage 
Based on this review, bleeding in the brain during or immediately after the surgery is the 
most critical adverse event that can risk the safety of the patient. In the DBS cases reporting ICH, 
the clot most often tracked along the lead and extended into the brain. Bleeding was not typically 
seen on the surface of the brain. The biggest difference between DBS and future neural implants 
is the type of electrode used. Since the Utah array is currently the only device used chronically in 
humans, and one of the arrays most likely to be incorporated into future modular devices, we will 
focus on this array. While a DBS lead extends several centimeters into the brain, the Utah array is 
much shallower, inserting only 1.5 mm into the brain. Therefore, if most of the bleeds that occur 
in DBS are not on the surface, it is likely that the DBS lead is perturbing blood vessels  deeper in 
the brain that the Utah array would miss (Kozai et al., 2010). It is possible that the incidence rate 
of ICH experienced in DBS could be an overestimate of what we would see in future intracranial, 
modular neuroprosthetic systems. In any case, bleeds can be very serious, but they are expected, 
and protocols have been established to manage them. 
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3.5.2 Infection 
Infections pose the highest risk for terminal explantation of the DBS entire system (20.7%). 
Reported infections were predominantly found at the site of the IPG, followed by the burr hole, 
and then the extension cable. While in DBS there is only one IPG, in the case of the NNP and other 
future modular systems, there will be many more “IPGs” and extension cables routed throughout 
the body. This has the potential to increase the rate at which infections arise and possibly affect 
their ability to spread throughout the body. Infections in DBS are typically managed with 
antibiotics, or portions of the system may be explanted while antibiotics is administered and then 
successfully re-implanted. Re-implantation is the main treatment for infection in such systems. 
While they are categorized as serious adverse events, they are very common. Future modular 
systems may have the potential for increased incidence of infection, however this does not 
necessarily have to be a failure of the system. As seen in DBS, revision procedures occur frequently 
without ultimately ending the therapy.  
3.5.3 Skin Erosion 
Skin erosion, while occurring less frequently, commonly occurs with infection. When there 
is erosion or breakage of the skin the area becomes susceptible and leads to infection of the area. 
Since skin erosion was most likely to occur over the IPG, a modular system with multiple IPGs, 
as proposed with the NNP and potential future devices, may experience an increased incidence 
rate than reported in DBS. Knowing this we can begin to investigate surgical procedures for the 
best placement of these IPGs throughout the body and how to implant them deeper as to reduce 
the risk of erosion. Similar to infection, cases of skin erosion are also categorized as serious, 
requiring a surgical revision. This may be treated with wound debridement but is most likely to 
lead to explantation of a portion or the whole system. 
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3.5.4 Extension Cable Malfunctions 
Although there was a low incidence rate of extension cable malfunctions in comparison to 
the other adverse events in DBS, this is vital information. The addition of a wire to connect the 
Utah array to an implantable module is where most of the uncertainty lies with the safety of future 
intracranial, modular devices. Malfunctions of the extension cable usually involve Twiddler’s 
syndrome or bowstringing which can lead to fracture of the cable or displacement of the electrode. 
One of the biggest risks with future Utah array tethered devices is that tension on the extension 
cable has the potential to dislodge the implanted array. However, of all the reported extension 
cable malfunctions, none led to the displacement of a DBS electrode, likely due to anchoring at 
the burr hole. All complications were due to breakage of the cable, which were then replaced. Most 
of the complications with the extension cable occur in the neck, however with future Utah array 
tethered devices the module directly connected to the Utah array will be secured to the skull. This 
smaller device may decrease the risk for potential electrode array dislodgement. 
 
3.5.5 Utah Array Safety and Longevity 
Utah arrays have been implanted in substantially fewer individuals, for shorter duration, 
and the literature does not contain much about the safety of these implants as compared to DBS, 
which has a sufficiently large population to reveal rare safety events. Since there has been no 
publication to date that explicitly discusses the risks or adverse events that occur in chronic human 
implants, we systematically reviewed all the published literature to address this topic. We 
identified 48 individuals implanted with a Utah array and determined the duration of implantation 
at the time of the study. This represents a starting point for a safety dataset of all FDA monitored 
studies. Acute studies are more common and have been the dominant contributor to the population 
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of subjects with Utah arrays. While long-term effects are not observed in these subjects, 
observations from short term studies help to estimate intra- hemorrhage, although not explicitly 
mentioned or discussed in any papers we reviewed. Infection typically prompts explantation of the 
array, so array longevity provides a lower bound on the period of time without serious infection or 
other adverse event. The mean number of days of Utah array implantation across all participants 
was 578. This underestimates implant time. With the exception of one paper, no study reported 
array explantation. In the absence of complication, participants typically remain implanted 
following the conclusion of the study.  
Because DBS systems are clinically available and have been implanted in many patients, 
incidence rates of DBS adverse events serve as a risk profile benchmark for future Utah array 
modular systems. Understanding the potential risks and failure modes of a device and how many 
people must be observed to witness such risks is important information when designing a clinical 
trial. For example, we conducted a power analysis to estimate the number of patients implanted 
with the Utah array needed to see similar incidence rates as DBS. We found that it would take a 
very large amount of people within a clinical trial before we would begin to see complications 
with similar incidence rates as DBS systems. By contrast, if Utah array tethered devices introduced 
5x the risk of DBS we would be able to see it much earlier and with fewer people (table 3.6). Given 
the low incidence rate of infection in DBS, we would not have expected to see any complications 
in cases with as few as 18 chronically implanted Utah arrays. It is also notable that these Utah 
arrays were all percutaneous and would likely have a higher infection rate than a fully implanted 
system.  
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The large number of people needed to do a true safety study is far off. However, few 
individuals are required to demonstrate the efficacy of neuroprosthetic systems. Efficacy may 
therefore have to be established before safety studies can begin. Early feasibility human trials 
would be beneficial in not only moving the needle in technology surrounding the future of 
implantable intracortical devices, but also helping to increase the population of people with these 
devices for a comprehensive understanding of safety over time. 
Table 3.6.  Example Power Analysis 
 
3.5.6 Study Limitations 
There is currently no standard reporting for adverse events related to DBS hardware or 
Utah array safety, thus this review is incomplete. There were some DBS articles that contained 
data on hardware-related complications that were excluded because either the information was too 
general (i.e. grouping infections and skin erosions and other skin complications together) or the 
data was per electrode lead and not per patient. Papers also generally lacked the time in which 
adverse events took place. In addition, papers discussing human research with the Utah array did 
not disclose any adverse events and some lacked important details such as the implantation date. 
Ultimately, safety questions will be best addressed in a sufficiently powered, prospective clinical 
trial. In the meantime, pilot studies will continue to contribute valuable data points over time by 
Complication Sample size needed to reject Null    Power (1-β) α 
1.5x 2x 5x 
Infection 602 167 15 .80 .05 
Skin erosion 692 193 18 .80 .05 
Hemorrhage 956 267 25 .80 .05 
Extension cable malfunctions 1555 435 41 .80 .05 
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including implant and explant dates and the time frame of experiments. As this literature grows, 
these data will better inform future device and clinical trial design. 
3.6 Conclusion 
Through systematic review of the clinical and human-trial literature, our study provides the 
most comprehensive safety review to date of DBS hardware and human neuroprosthetic research 
using the Utah array. The evidence-based analysis serves as an important reference for 
investigators seeking to meet regulatory requirements and to design clinical trials for future 
intracranial, fully implanted, modular neuroprosthetic systems. 
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Chapter 4 
Reporting of Incidental Safety Data of the Utah Array in a Rhesus Macaque 
 
4.1 Abstract 
Brain machine interfaces have the potential to restore function and improve the quality of 
life for many people. However, there is much that still needs to be explored in terms of the tissue 
responses that contribute to the failure of intracortical electrodes in order to transition to routine 
clinical adoption. The stability and longevity of these arrays are critical factors for determining 
whether the clinical benefit outweighs the risk for potential users. Here we investigate the extent 
of damage in neural tissue from post-mortem histology of a rhesus macaque implanted with two 
Utah arrays for 818 days. Tissue was stained for neurons, microglia, and nuclei. We quantified the 
neuron density from eight sampled locations under the array in comparison to tissue surrounding 
the array on three different slices using ImageJ. The neuron density for the sampled tissue 
surrounding the Utah array averaged across all three slices was 37,559 neurons/mm3. The mean 
neuron density of the 8 samples from under the array averaged across the three slices was 8,192 
neurons/mm3, which is a 78.3% reduction. Due to large amounts of remodeling and uncertainty in 
the exact depth of the slices used for sampling, the layer of brain cannot be determined. These 
initial histologic findings give preliminary insight into the potential damage of a chronic Utah 
array. However, additional histology from more primates are needed for further investigation.
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4.2 Introduction 
Brain machine interfaces (BMIs) have shown great potential to restore motor and sensory 
functions to those suffering from neurological disorders. These devices require an intracortical 
electrode array to record neural activity with a high level of specificity across a large population 
of neurons in order to control computer cursors and robotic arms (Nordhausen et al., 1996). The 
Utah array (Blackrock Microsystems), a silicon based intracortical microelectrode array, is the 
current state-of-the-art electrode array that has been used to study memory, anesthesia, cognition, 
as well as for BMI applications in numerous animal and human clinical studies (Collinger et al., 
2013b; Gilja et al., 2012; Hochberg et al., 2012b; Z. T. Irwin…Bullard et al., 2017; S.-P. Kim et 
al., 2008; Velliste et al., 2008; Schroeder…Bullard et al., 2017). Reportedly, the longest lasting 
case of a functional Utah array in a human has been approximately 5.4 years during the BrainGate2 
clinical trial (Masse et al., 2014). While this provides encouragement around the concept of multi-
year recordings with the Utah array, studies with non-human primates show indications that the 
array fails at many different time intervals.   
 The stability and longevity of these arrays are critical factors for determining whether the 
clinical benefit outweighs the risk for potential users. Despite improvements in electrode 
technology, an intracortical microelectrode that can function reliably for at least a decade has yet 
to be introduced to the field of BMI. As a consequence, many studies have been done to investigate 
the failure mechanisms of silicon electrodes that threaten long-term recordings (Barrese et al., 
2013; Prasad et al., 2012). Previous studies have demonstrated that the signal quality recorded 
from the Utah array generally attenuates over time  (Chestek et al., 2011), which may ultimately 
lead to the functional loss of the array.  
59 
 
Among the key factors implicated in the failure of the arrays, tissue response and 
integration prior to implantation is suggested to be one of the main contributors (Barrese et al., 
2013; Welle, Street, Ruda, Civillico, & Takmakov, 2017).  This tissue response to the electrodes 
has been well studied, investigating mechanisms consisting of fibrotic tissue encapsulation, glial 
scarring, inflammation, and neuronal migration and death (Barrese, Aceros, & Donoghue, 2016; 
Biran, Martin, & Tresco, 2005; Black et al., 2018; Nolta, Christensen, Crane, Skousen, & Tresco, 
2015; Polikov, Tresco, & Reichert, 2005; Stiller et al., 2018; Szarowski et al., 2003; Turner et al., 
1999). Histological data used to study these mechanisms chronically, have been primarily from 
rats and cats. Due to ethical reasons and cost it is very difficult to obtain post-mortem histological 
data to study these tissue responses in non-human primates or humans.  
While monkeys are rarely perfused, in this rare case, we performed a euthanasia and 
perfusion on a rhesus macaque chronically implanted with Utah microelectrode arrays at the end 
of their experimental lifetime. Here we investigate the long-term neuronal damage from tissue 
under the implant site and compare neuron densities with control brain areas within the same 
animal. This explores the question of safety surrounding chronic implants that can’t be studied in 
humans. Additionally, the findings of this work will help further expand the small pool of data for 
histology of chronically implanted arrays in non-human primates. 
 
4.3 Methods 
4.3.1 Surgical Implantation 
All animal procedures were approved by the University of Michigan Institutional Review 
Board and the Institutional Animal Care & Use Committee. Four Utah arrays (Blackrock 
Microsystems) were implanted in a male rhesus macaque. Two were implanted in the primary 
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motor (M1) and sensory (S1) cortex of the left hemisphere on August 20, 2015. The remaining 
two were implanted similarly on the right hemisphere on May 4, 2016. Only the tissue from the 
arrays in the left hemisphere were stained and imaged, and included in the results below. These 
two arrays were implanted for 818 days. The electrode tips of the array in M1 consisted of IrOx, 
while the electrode tips of the array in S1 consisted of IrOx and aluminum oxide coating. 
  For each original implantation, the monkey was induced under general anesthesia and 
placed in a stereotactic frame. The craniotomy site was located using the stereotactic frame to 
estimate the location of the central sulcus. Following the craniotomy, the dura was resected and 
arrays were inserted using a pneumatic inserter (Blackrock Microsystems). The dura was closed 
and duragen was laid over the craniotomy site. The bone flap was then replaced and secured with 
titanium screws. Dental acrylic was applied to secure the connectors and build up a head cap. 
 
4.3.2 Perfusion and Tissue Processing 
The animal was perfused transcardially, December 15, 2017, with 1X Phosphate Buffer 
Saline (PBS) until the exudate was clear and then fixed with 4% paraformaldehyde (~1000 ml, 
Electron Microscope Sciences). Due to the protocol, perfusion could not be performed under 
anesthesia, thus ex vivo perfusion began approximately 4 minutes after the death was confirmed 
by the veterinarian. The brain was carefully removed from the skull approximately 4 hours after 
perfusion and was further immersion fixed in 4% paraformaldehyde for 72 hours, followed by an 
additional 48 hours after the removal of the skull and arrays to further fix the tissue under the array 
and bone growth. Gross dissection of the tissue surrounding the implantation sites was performed 
and the tissue was fixed in 4% paraformaldehyde (PFA) for 5 days and then stored in 1X PBS for 
8 days at 4oC. To cryoprotect the tissue, samples were put in 30% sucrose (Sigma) in 1X PBS at 
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4oC for 26 days to reach equilibrium. The tissue was frozen at -80oC in optimal cutting temperature 
compound (Sakura Finetek) and sliced perpendicular to the implantation sites in 100 μm sections 
at -16oC. Slices were stored in 0.02% azide (Dot Scientific) in 1X PBS at 4oC until 
immunohistochemical labeling. 
 
4.3.3 Explantation of Arrays. 
Explanatation of the Utah arrays began after perfusion of the rhesus macaque. The methyl 
was carefully removed with a handheld drill. A 2-3 cm bone flap, overlaying the arrays, was 
outlined by drilling the bone down to the dura. Dura growth on top of the arrays was cut away and 
the arrays were excised using forceps. Following explantation, the arrays were placed in Benz-All 
overnight and switched to 1X PBS the next day, to be preserved for future analysis. 
 
4.3.4 Tissue Staining 
Tissue slices were blocked and permeabilized overnight in StartingBlock-PBS (Thermo 
Fisher) containing 0.1% Triton-X 100 (Sigma) at 4oC. Then, the tissue was washed three times 
(30 min per wash) in PBS containing 0.5% Triton X-100 (1X PBS-T) at room temperature. The 
tissue was then incubated in primary antibodies with 0.5% PBS-T for three days at 4oC. Primary 
antibodies used were mouse anti-neuronal nuclei (NeuN) (1:250, Millipore) for neurons, rabbit 
anti-Iba-1 (1:250, Wako) for all microglia/macrophages, and rabbit anti-glial fibrillary acidic 
protein (GFAP) (1:250, Dako) for astrocytes. The tissue was washed three times (30 min per wash) 
in 0.5% PBS-T at room temperature. Tissue was then incubated in secondary antibodies with 0.5% 
PBS-T for one day at 4oC. Secondary antibodies used were anti-mouse Alexa Fluor 647 (1:250, 
Jackson) and anti-rabbit Alexa Fluor 546 (1:250, Life Technologies). Hoechst (1:250, Thermo 
Fisher) a stain for all cellular nuclei, was added as well. Following incubation, the tissue slices 
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were washed in 0.5% PBS-T two times at two hour intervals and then kept in PBS overnight. All 
slices were stored at 4oC in PBS with 0.02% azide until ready to image. 
4.3.5 Imaging 
All imaging was performed by the Cai Lab. Slices were mounted in Vectashield mounting 
medium (Vector Labs) and imaged using a 20X objective on a confocal microscope systematic 1-
µm intervals in the z-dimension on a Zeiss LSM780 using 405nm and 633nm lasers for excitation 
together with -405 and 488/543/633 dichroic mirrors. Images were then stitched using the ImageJ 
Grid/Collection Stitching Plugin. 
4.3.6 Cell Counting 
Slices were collected beginning from the top of the tissue sample along the depth of the 
array, each 100 µm thick. Due to the uncertainty of the exact location of the initial slice in relation 
to the surface of the brain and large amounts of remodeling, we have no landmarks to determine 
the layer of brain captured in the following slices. Slices 9, 12, and 13 were used in this analysis 
at depths of 800-900 µm, 1100-1200 µm, and 1200-1300 µm from the top of the tissue sample. 
Images stained for NeuN were analyzed using Image J. Neurons were directly counted manually 
within a known volume using techniques from the fractionator approach (West, 1999). Using the 
Image J Cell Counter Plugin and the multi-point function, neurons were labeled when first visible 
within the z-stack of a slice to ensure they were only counted once. In addition, a fluorescent 
intensity threshold was set to remove some of the counting bias in determining neurons from 
background. 
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4.4 Results 
4.4.1 Gross Pathology 
 Upon explantation of the arrays we found that the array implanted in M1 was completely 
encapsulated by dura or scar tissue as seen in figure 4.1 (B). This growth formed around the array 
and ultimately pushed it out of the brain. There was an impression left on the brain of the general 
outline of the array, but no visible holes on the surface of the brain left from the penetrating shanks, 
shown in figure 4.1 (C). The imaged slices from neural tissue under this M1 array was consistent 
with this as well. While the tissue did contain neurons, with no holes from the electrode shanks 
present in the images, we were unable to determine orientation or the location of the array for 
further analyses. Therefore, this tissue was not use in the results below. 
 The S1 array remained embedded in the brain with typical growth on top as seen in figure 
4.1 (D). This array did leave an impression and holes where the shanks had penetrated the brain, 
shown in figure 4.1 (C). This impression was used in analysis of the stained images to determine 
the orientation of the array and decipher between tissue under the implant and the surrounding 
area, which was used as control brain in this study.  
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Figure 4.1. Gross Histological Results. A) Surgical photo of implanted Utah arrays. B) M1 array fully 
encapsulated and displaced from the brain at 818 days post implant. C) Impressions left on the brain after 
array extraction. D) S1 implant covered with dura. 
4.4.2 Neuron Density 
We used multiple stains to look at the extent of damage under the implanted array. The 
Hoechst stained for nuclei of cell bodies, Iba-1stained for microglia, and NeuN stained for neurons 
(figure 4.2).  
 
Figure 4.2. Histological Stains. Hoechst stains for nuclei. Iba-1 stains for microglia. NeuN stains for 
neurons. 
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Damage to the neural tissue from the implantation of the Utah array was characterized by 
investigating the neuron densities from areas under the array and areas surrounding the array of 
the same monkey. Neuron density was quantified using the number of neurons per cubic 
millimeter. Three 100 µm thick slices estimated to be at depths of 800-900 µm, 1100-1200 µm, 
and 1200-1300 µm along the electrode array were analyzed to determine any damage. The layer 
of brain captured in these three slices are unknown. Due to the compromised images on the top 
and bottom of each slice, potentially from tissue degradation, the first and last few z-stacks of each 
slice were discarded. The remaining 70 µm thick slices were used for further analysis. The imaging 
window of each slice varied slightly, resulting in differences in the amount of tissue surrounding 
the array available as a control sample.  Thus, a standard area of approximately 600 µm x 400 µm 
was used to sample control brain for each slice. The exact same area boundary was used to sample 
the neural tissue from eight locations under the array for each slice, shown in Figure 3. The array 
was broken down into four quadrants and two locations from each quadrant were chosen randomly 
with uniform distribution using Matlab. 
 
Figure 4.3. Neuron density comparison between neural tissue under the array and surrounding the array 
(control) from slice 13. The location from where the samples are taken is outlined in the full image. 
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In the comparison of neuron densities in the tissue under the array and the surrounding 
area, it is immediately visible that there is a drastic decrease in the number of neurons present in 
the neural tissue that was under the Utah array, as seen in figure 4.3. The neuron density for the 
sampled tissue surrounding the Utah array averaged across all three slices was 37,559 
neurons/mm3. The mean neuron density of the 8 samples from under the array averaged across the 
three slices was 8,192 neurons/mm3. The variance of the averaged neuron densities across the 
samples under the array in comparison to sampled tissue surrounding the array are depicted in 
figure 4.4. The sampled area under the array of the three depths (800-900 µm, 1100-1200 µm, 
1200-1300 µm) experienced a decline of 78.3% in the number of neurons present in the same 
volume. 
 
 
Figure 4.4. Neuron density for each sampled location averaged across the three slices analyzed. 
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4.5 Discussion 
The longevity of the Utah array used for BMI experiments has always been in question. 
Will it last long enough for the benefits to outweigh the risk of surgical implantation?  Mechanisms 
previously reported to contribute to the failure of the array consist of tissue response, material 
degradation, and mechanical failures (Barrese et al., 2013). The purpose of this study was to further 
explore the reactive tissue response threatening long-term recordings of the Utah array. 
Specifically, we took the rare opportunity to analyze post-mortem histology of neural tissue from 
a rhesus macaque implanted with the Utah array for approximately 818 days to investigate damage 
during chronic implantation.  
Upon extraction, the array implanted in M1 was noticeably encapsulated and had been 
displaced from the brain. This failure mechanism adheres to the literature, with reports of 
encapsulation of an array as early as 1956 (Collias & Manuelidis, 1956). Kim et al 2004 explained 
that meningeal fibroblasts migrate down the shank of the electrode from the top of the cortex 
enclosing the array, which was seen here as well (Y.-T. Kim, Hitchcock, Bridge, & Tresco, 2004). 
Due to the displacement, the histology lacked an electrode footprint in order for us to determine 
orientation and continue our analysis. 
There have been numerous studies on the formation of the glial scar as a response to the 
electrode. The glial scar is typically completely formed within 6-12 weeks of implantation and is 
most severe 50-100 µm from the array (Turner et al., 1999). This increases the distance between 
the electrode and neurons and usually results in a graded loss of neurons closest to the electrode 
(Biran et al., 2005; Biran, Martin, & Tresco, 2007; Potter-Baker et al., 2014). Our histologic 
findings from the tissue under the array implanted in S1support the claims of progressive neural 
remodeling as a long-term failure mechanism. We believe something is occurring after the 12 
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weeks once the glial scar is already completely formed, having a longstanding effect on the neuron 
density at a time point further out. The lack of neurons in close proximity to the electrode has been 
shown to reduce recorded signal quality and can further lead to the loss of an array (Buzsáki, 2004). 
 We quantified the gross neuronal damage under the array. Our results suggest that in the 
layers we analyzed the neural tissue under the chronic Utah array implant had a decreased neuron 
density and size in comparison to the surrounding area. The size of the neurons from tissue under 
the array were also visibly smaller in comparison to the tissue surrounding the array. While tissue 
slices more dorsal had overall smaller neurons, typical to a higher layer (García-Cabezas & Barbas, 
2014), the size between tissue under the array was very different than surrounding areas. We 
measured a 78.3 % smaller number of neurons from three different depths under the array 
compared to adjacent tissue. While this is a dramatic reduction, there are many limitations of this 
study that make it difficult to understand exactly what is happening. Neuron death is a possibility; 
however, the neurons could also be experiencing migration down past the array. This is consistent 
with results seen by the Welle Lab and Donoghue Lab (Barrese et al., 2013; Welle, 2018). The 
exact distance of the slices used in this analyses are unknown and we do not know the layer of 
brain, however we can estimate based on the slice thickness and number that the samples were 
from a tissue depth of 800-1300 µm. This range is not large enough to include the electrode tips 
or tissue further ventral, therefore we could not investigate the possible migration of neurons 
downward. In addition, the sample of surrounding tissue used as our control contained about half 
the neuron density than what is reported in the S1 of a rhesus macaque with no implant (Collins, 
Airey, Young, Leitch, & Kaas, 2010). The inconsistency in neuron density for our control could 
be a reflection of the location, immediately adjacent to the array, the size of the sample, or simply 
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differences between monkeys. However, the limited histological reports in the literature make it 
difficult to determine.  
Based on our initial observations that neural tissue from a chronically implanted Utah array 
experience a drastic decrease in the number of neurons, questions of potential motor deficits as a 
result and the appropriate patient population arise. Currently, people implanted with these arrays 
already have severe loss of motor functions due to spinal cord injury. However, as technology 
advances and the applications of BMI expand, discussions of the injury threshold suitable for such 
a device may become more critical. For example, can brain-controlled functional electrical 
stimulation only be used in people with high cervical level injury (C1-C3) or can it be expanded 
to others (C4-C6) with slightly more residual motor function? Contrary to the human clinical 
studies, in this study, the Utah array was implanted in an able-bodied rhesus macaque. 
Interestingly, despite the dramatic decrease of neurons present, the animal showed no signs of any 
motor deficits and continued to move freely over a year after the array was no longer in use due to 
poor signals. This behavioral response has also been shown in studies investigating neuronal death 
from moderate traumatic brain injury and resection in rats and similarly in humans, where 
moderate motor deficits recovered over time or were unnoticeable (Feeney, Gonzalez, & Law, 
1982; Magill, Han, Li, & Berger, 2018; Ouyang, Yan, Zhang, & Fan, 2017).  While there are 
considerable complexities of the brain, the recovery or lack of motor deficits experienced may be 
the outcome of the transition of motor control to another intact area. 
4.6 Conclusion 
Brain machine interfaces have the potential to restore function and improve the quality of 
life for many people. However, there is much that still needs to be explored in terms of the tissue 
responses that contribute to the failure of intracortical electrodes in order to transition to routine 
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clinical adoption. The initial histologic findings of the one rhesus macaque reported here give 
preliminary insight into the extent of possible neural damage under a Utah array. Due to the limited 
body of literature, no true judgements can be made. Additional histology from more primates are 
needed, however, this work can contribute to minimal existing dataset. 
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Chapter 5 
Discussion 
5.1 Conclusion 
Brain machine interfaces have provided an intuitive alternative to restore arm and hand 
function to those suffering from paralysis due to spinal cord injury. However, there are still many 
challenges involved in translating this technology into a system that can be used practically in a 
clinical setting. In this thesis, we attempt to address these challenges and present a plausible 
solution to the development of fully implantable technology. By investigating the design and safety 
specifications to meet regulatory requirements we hope to expedite the path to a clinically-viable 
system. 
First, In Chapter 2 we designed a neural recording device to access a 96-channel Utah 
array, the state-of–the-art electrode for human BMI experiments, and mate with the NNP, an 
existing implantable FES system. Using the spiking band as a neural feature provided an 
opportunity to decimate the data while preserving the important neural information to predict 
motor intent. Extracting signals in a smaller bandwidth, instead of the full broadband waveform, 
allowed for a reduction in the large processing overhead of the front-end leading to power savings, 
as seen previously in a 16-channel system (Irwin…Bullard et al., 2016).  This construct formed 
the basis of the device architecture, which fit within the packaging guidelines and manufacturer 
capabilities of existing NNP modules. We also tested the device could record and transmit 96 
channels of data in a power consumption range similar to existing NNP modules without 
compromising signal integrity
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 Naturally, with the goal of creating a functional fully implantable device for clinical use, 
the next step is to design a clinical trial. This will require an exhaustive analysis of the safety risks 
associated with a fully implantable cortical-controlled FES system. Both the NNP system and Utah 
array have been implanted in humans and have gone through clinical trials, however they have 
never been conjoined together in a single system. It is unclear what safety risks may be associated 
with combining these two systems. There are currently no adequate or standard quantifications of 
risks and the percent chance of having a major safety problem with the conjoined system is 
unknown. Thus, Chapter 3 analyzed the safety profiles of existing implantable, intracranial devices 
in humans. Using a systematic approach, we identified potential sources of hardware-related 
complications in the literature and quantified the incidence rate and severity of adverse events. 
This study provided the most comprehensive safety review to date of DBS hardware and human 
BMI research using the Utah array. Understanding the potential risks and failure modes of a device 
and how many people must be observed to witness such risks is important information when 
designing a clinical trial. Therefore, the evidence-based analysis serves as an important reference 
for investigators seeking to meet regulatory requirements for an intracranial, fully implanted, 
modular neuroprosthetic system.  
While much information on the safety of a device can be gained through observing human 
clinical trials, there are limitations, in which animal models may offer more opportunities for 
additional analyses. In Chapter 4 we take a deeper look at the biological response of the brain after 
the implantation of the Utah array. We quantified neuron density around the shanks of the array to 
examine damage of the neural tissue. Histological results from the three tissue slices analyzed 
suggest there is a reduction in the number of neurons in neural tissue under the array compared to 
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surrounding tissue. These initial results can be used to increase the database of safety data for the 
Utah array and can be used to inform the development of future devices. 
5.2 Future Directions 
5.2.1 Modular Systems 
Over the years there has been an increased interest in research surrounding body area sensor 
networks (Ha, 2015) . This concept of incorporating a network of multiple sensors throughout the 
body has great potential to revolutionize the future of the healthcare system. The advancement of 
implantable electronics and wireless communication provide opportunities to develop novel and 
innovative sensor platforms for various applications. These modular systems have been adapted 
for use in continuous sensing and monitoring for smart health care, assisted elderly living, and 
emergency response (Fortino & Gravina, 2015; Gyselinckx, Vullers, Hoof, Ryckaert, & 
Yazicioglu, 2008; Hadjem, Salem, & Nait-Abdesselam, 2014; Milenković, Otto, & Jovanov, 2006; 
Ullah et al., 2010).  
The modular, implantable brain-controlled FES system described in Chapter 2 further 
adheres to this trend of body area sensor networks. With the ultimate goal of establishing one 
system with the capability to address multiple function loss instead of several implantable systems 
for each individual impairment, the development of our neural recording module can be used as a 
guide to develop future application specific modules. This is important because spinal cord injury 
severely interferes with a number of daily functions, not only arm and hand mobility, but 
potentially trunk stability, bowel and bladder control, and walking. 
 Our neural recording device was designed to acquire data at configurable bandwidths, 
sampling rates, and channel counts using the Intan bioamplifiers, offering the possibility to be used 
for applications outside of Utah array recordings. This technology expands the functionality of the 
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device to accept different signal modalities and can be adapted to support other closed loop 
applications such as closed loop DBS, seizure prevention, and bladder state monitoring 
(DiLorenzo, Mangubat, Rossi, & Byrne, 2014; Khurram et al., 2017; Stanslaski et al., 2012; Sun 
& Morrell, 2014). Reconfigurable systems provide an interface to multiple implantable platforms 
and are an attractive new capability of the next generation of devices. Draper has developed an 
implantable, wireless, radio-powered neural stimulation device that can be used for multi-modal 
recording and stimulation, controlled by an external transmitter (Bjune et al., 2015; Wheeler et al., 
2015). The combination of high density electrodes, multi-modal recordings, and adaptive closed-
loop stimulation will enable therapies to address a number of neurological disorders in both the 
central and peripheral nervous system and make it a great contender to function as a network of 
devices in the future. 
5.2.2 Neural Signal Origin 
While promising, there are still many avenues of research in need of exploration to advance 
our understanding and further improve our proposed implantable brain-controlled FES system and 
influence emerging neuromodulation technologies.  The use of the spiking band power to decrease 
the size of the data transmitted is essentially the driving force in the architecture of our neural 
recording device. This feature allows for a dramatic reduction in power which makes our device 
feasible for use as an implantable module. If embraced, this concept could be used to further 
advance current experimental systems still using the typical broadband signal extraction (Borton 
et al., 2013; Rizk et al., 2009). In addition, because of the preferred spiking band frequency range, 
devices originally designed to process LFP and ECoG could use this technology to access 
sufficient neural information for brain machine interface applications as well (B. C. Johnson et al., 
2017; Mestais et al., 2015; Robinet et al., 2011). 
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We have shown that signal power within 300-1000 Hz can be used to predict motor intent 
just as well as threshold crossings (Irwin…Bullard et al., 2016; Stark & Abeles, 2007). However, 
these studies used fairly simple tasks, which may not have exposed any discrepancies just yet. 
Currently we do not know if spiking band power will perform well enough as a neural feature to 
decode more complex tasks needed to fulfill functional daily activities. The neural origin and 
content within the 300-1000 Hz frequencies is not well understood. This lack of understanding in 
the fundamentals of the recorded signal provide difficulties when predicting the limitations of its 
decoding performance. Speculations around whether the spiking band power is a relatively local 
signal similar to threshold crossings or a broader LFP signal persist. However, the comparison of 
spiking band power and averaged thresholded crossings investigated in Chapter 2 support the 
notion that spiking band is mostly reflective of spiking activity.  
Studies have shown that while correlation between LFPs and single unit recordings may 
be weak, LFPs may be more useful in encoding information like speed (Perel et al., 2015). Because 
the spiking band frequency range encompasses those of LFPs and spikes, it may have the potential 
to provide more information on both speed and velocity. This may be a possible advantage over 
using only threshold crossings for BMI decoding. Additionally, acquiring the spiking band power 
does not require spikes to be visible within the single, which allows it to still interpret useful data 
from channels that over time no longer have good quality spikes, ultimately extending recording 
lifetime. Similar approaches have been made, adding high frequency local field potential activity 
to decoding models to improve performance as the array condition diminishes (Ajiboye et al., 
2017; Pandarinath et al., 2017b; D. Wang et al., 2014). 
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5.2.3 Innovative Electrode Technology 
 The longevity of the Utah array used for BMI experiments has always been in question. 
Will it last long enough for the benefits to outweigh the risk of surgical implantation?  Baresse et 
al. investigated factors that posed a threat to the longevity of the array including mechanical 
damage of the electrode, degradation of electrode materials, and the response of the brain after 
implantation. Biological issues were reported as the second most common, accounting for 24% of 
array failures (Barrese et al., 2013). Studies have shown that after the insertion of the silicon-based 
array into the brain a glial scar forms in response, around the shank of the electrode. This scar can 
extend up to 250 µm and make it difficult to record signals within a 100-200 µm radius surrounding 
the electrode  (Biran et al., 2005). Chapter 4, quantifies the damage of the neurons surrounding the 
electrodes in response to insertion and gliosis, which ultimately led to poor signal quality and a 
substantial reduction in efficacy of the BMI. This reactive response seen with multi-electrode 
arrays such as the Utah array, led groups to explore different electrode designs to decrease damage 
of neural tissue.  
Carbon fiber electrodes may be well suited to address these challenges seen in silicon-
based electrode arrays. The small diameter of the fiber allows for insertion without the negative 
biological response of scarring and neuronal death around the electrode (P. R. Patel et al., 2016). 
Therefore, there is increased neuronal density in the zone of recording which could lead to a longer 
recording lifetime for use in BMI. In addition, because the large radius of neuronal death around 
the electrode has been eliminated, carbon fibers may be used to increase channel count in a high 
density array (Massey et al., 2019). Having access to more channels may in return lead to a larger 
resolution of the neural information and more accurate and advanced decoding. 
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Additional novel experimental electrodes have been designed with goal of eliminating the 
negative biological response to implantation by decreasing the size and improving the flexibility 
of the electrode. Neural dust, consists of ultra-miniature, free-floating, independent sensor nodes 
for recording and communication and have been used in the brain and nerve (Seo et al., 2016; Seo, 
Carmena, Rabaey, Maharbiz, & Alon, 2015). While this new neural recording platform addresses 
many challenges seen with the Utah array, scaling this system to include hundreds of individual 
electrodes may not be ideal for surgical implantation. One potential way to record from a large 
number of neurons is with a high density mesh electrode (Fu, Hong, Viveros, Zhou, & Lieber, 
2017). The development of mesh electronics bridge the gap between scalability and flexibility and 
have shown to integrate successfully with the brain without chronic gliosis (Liu et al., 2015; Xie 
et al., 2015).  
There has been significant progress made in the field of brain machine interfaces and the 
goal to restore arm and hand function to those suffering from paralysis. While there is still a long 
path towards a clinically viable system, continuing the research on these challenges will help 
advance the field. Additionally, building upon the results of this work, as we continue to collect 
data on the safety and efficacy of neuromodulation systems, we lay the foundation for a strong 
database of information that can be used to help groups meet the regulatory requirements needed 
to translate emerging, innovative technologies to human clinical trials.
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